Exhibit
10.1


 


SECURITIES
PURCHASE AGREEMENT


 


This
Securities Purchase Agreement (this “Agreement”) is dated as of November 4, 2016 by and amount, NAC Global Technologies,
Inc., a Nevada corporation (the “Company”), NAC Drive Systems, Inc., a Delaware corporation (“NACD”),
and the purchaser identified on the signature pages hereto (each, including its successors and assigns, the “Purchaser”).



 


WHEREAS,
subject to the terms and conditions set forth in this Agreement and pursuant to Section 4(a)(2) of the Securities Act of
1933, as amended (the “Securities Act”), and Rule 506(b) promulgated thereunder, NACD and the Company desire
to issue and sell to the Purchaser, and the Purchaser, desires to purchase from NACD and the Company, securities of NACD and the
Company as more fully described in this Agreement, and thereafter exchange such NACD securities for Preferred Shares in accordance
in accordance with the terms hereof;


 


WHEREAS,
the Board of Directors have approved the creation and authorization of the Series A Preferred Stock;


 


WHEREAS,
a majority of the Company’s stockholders have approved the creation and authorization of the Series A Preferred Stock;


 


WHEREAS,
pursuant to the foregoing resolutions by the Board of Directors and a majority of the Company’s stockholders, the Company
filed with the Commission on November 3, 2016, a Preliminary Information Statement on Schedule 14C with respect to, among other
matters (i) the Company’s stockholders’ approval of the creation and authorization of the Series A Preferred Stock,
and (ii) the Company’s stockholders’ approval of a reverse stock split of the Company's common stock in a ratio ranging
from 50-to-1 to 200-to-1;


 


WHEREAS,
the Company shall file a Definitive Information Statement on Schedule 14C with respect to, among other matters (i) the Company’s
stockholders’ approval of the creation and authorization of the Series A Preferred Stock, and (ii) the Company’s stockholders’
approval of a reverse stock split of the Company's common stock in a ratio ranging from 50-to-1 to 200-to-1;


 


WHEREAS,
subsequent to the filing of such Definitive Information Statement on Schedule 14C, the Company shall promptly file with the Secretary
of State of the State of Nevada the Certificate of Designations in accordance with the terms hereof; and


 


WHEREAS,
subsequent to the filing of the Certificate of Designations, the Company shall promptly issue to the Purchaser the Preferred Shares
in accordance in accordance with the terms hereof.


 




    


     

    

 


NOW, THEREFORE,
IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt
and adequacy of which are hereby acknowledged, the Company and the Purchaser agree as follows: 


 


ARTICLE
I. 


DEFINITIONS



 


1.1
  Definitions.  In addition to the terms defined elsewhere in this Agreement: (a) capitalized terms
that are not otherwise defined herein have the meanings given to such terms in the Certificate of Designations (as defined herein),
and (b) the following terms have the meanings set forth in this Section 1.1:


 


“Acquiring
Person” shall have the meaning ascribed to such term in Section 4.7.


 


“Action”
shall have the meaning ascribed to such term in Section 3.1(j).


 


“Affiliate”
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common
control with a Person, as such terms are used in and construed under Rule 405 under the Securities Act. 


 


“Board
of Directors” means the board of directors of the Company.


 


“Business
Day” means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or any
day on which banking institutions in the State of New York are authorized or required by law or other governmental action to close.


 


“Certificate
of Designations” means that certain Certificate of Designations, Preferences and Rights of the Series A Convertible Preferred
Stock of the Company, in the form of Exhibit J attached hereto.


 


“Closing
Dates” means the Trading Day(s) on which all of the Transaction Documents have been executed and delivered by the applicable
parties thereto in connection with a Closing, and all conditions precedent to (i) the Purchaser’s obligations to pay
the Subscription Amount as to such Closing and (ii) the Company’s obligations to deliver the Securities as to such
Closing, in each case, have been satisfied or waived.


 


“Closing(s)”
means the one or more closings of the purchase and sale of the Securities pursuant to Section 2.2.


 


“Closing
Statement” means the Closing Statement in the form on Annex A attached hereto.


 


“Collateral
Assignment of Receivables” means the Collateral Assignment of Receivables dated the date hereof, in the form of Exhibit
G attached hereto.


 


“Commission”
means the United States Securities and Exchange Commission.


 






    2


     

    

 


“Common
Stock” means the common stock of the Company, par value $0.001 per share, and any other class of securities into which such
securities may hereafter be reclassified or changed. 


 


“Common
Stock Equivalents” means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument
that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive,
Common Stock. 


 


“Company
Counsel” means Ellenoff Grossman & Schole LLP.


“Conversion
Price” shall have the meaning ascribed to such term in the Certificate of Designations or the Notes.


 


“Conversion
Shares” means the shares of Common Stock issued and issuable upon conversion or redemption of the Preferred Shares and issued
and issuable in lieu of the cash payment of interest on the Preferred Shares in accordance with the terms of the Certificate of
Designations.


 


“Disclosure
Schedules” shall have the meaning ascribed to such term in Section 3.1.


 


“Effective
Date” means the earliest of the date that the (a) initial Registration Statement has been declared effective by the
Commission, (b) all of the Registrable Securities have been sold pursuant to Rule 144, or (c) following the one
year anniversary of the Closing Date provided that a holder of Registrable Securities is not an Affiliate of the Company, all
of the Registrable Securities may be sold pursuant to an exemption from registration under Section 4(a)(1) of the Securities
Act without volume or manner-of-sale restrictions and Company counsel has delivered to such holders a standing written unqualified
opinion that resales may then be made by such holders of the Registrable Securities pursuant to such exemption which opinion shall
be in form and substance reasonably acceptable to such holders.


 


“Evaluation
Date” shall have the meaning ascribed to such term in Section 3.1(r).


 


“Exchange
Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder. 


 


“Exempt
Issuance” means the issuance of (a) shares of Common Stock or options to employees, officers, directors, advisors or independent
contractors of the Company pursuant to any stock or option plan duly adopted for such purpose, (b) shares of Common Stock, warrants
or options to advisors or independent contractors of the Company for compensatory purposes, (c) securities upon the exercise or
exchange of or conversion of any Securities issued hereunder and/or other securities exercisable or exchangeable for or convertible
into shares of Common Stock issued and outstanding on the date of this Agreement, provided that such securities have not been
amended since the date of this Agreement to increase the number of such securities or to decrease the exercise price, exchange
price or conversion price of such securities, (d) securities issuable pursuant to any contractual anti-dilution obligations of
the Company in effect as of the date of this Agreement, provided that such obligations have not been materially amended since
the date of this Agreement, and (e) securities issued pursuant to acquisitions or any other strategic transactions approved by
the Board of Directors, provided that any such issuance shall not include a transaction in which the Company is issuing securities
primarily for the purpose of raising capital or to an entity whose primary business is investing in securities.


 






    3


     

    

 


“Filing
Date” means the date the registration statement covering the Conversion Shares, or as applicable, the Underlying Shares
is filed with the Commission.


 


“First
Closing” means the closing of the purchase and sale of the Securities pursuant to Section 2.1.


 


“FCPA”
means the Foreign Corrupt Practices Act of 1977, as amended.


 


“GAAP”
shall have the meaning ascribed to such term in Section 3.1(h).


 


“Indebtedness”
shall have the meaning ascribed to such term in Section 3.1(aa).


 


“Intellectual
Property Rights” shall have the meaning ascribed to such term in Section 3.1(o).


 


“Liens”
means a lien, charge, pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.


 


“Material
Adverse Effect” shall have the meaning assigned to such term in Section 3.1(b).


 


“Material
Permits” shall have the meaning ascribed to such term in Section 3.1(m). 


 


“Maximum
Rate” shall have the meaning ascribed to such term in Section 5.17.


 


“Note”
or “Notes” mean the 5% Senior Secured Convertible Promissory Note(s) due, subject to the terms therein, twelve (12)
months from their date of issuance, issued by the Company to the Purchaser hereunder, as applicable, in the form of Exhibit A
attached hereto.


 


“Person”
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind. 


 


“Performance
Guarantees” means those Performance Guarantees dated the date hereof, in the form of Exhibit H attached hereto.


 


“Preferred
Shares” means the shares of Series A Preferred Stock issued to the Purchaser.


 






    4


     

    

 


“Pre-Notice”
shall have the meaning ascribed to such term in Section 4.12(b). 


 


“Pro
Rata Portion” shall have the meaning ascribed to such term in Section 4.12(e).


 


“Proceeding”
means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial
proceeding, such as a deposition), whether commenced or threatened. 


 


“Public
Information Failure” shall have the meaning ascribed to such term in Section 4.3(b).


 


“Public
Information Failure Payments” shall have the meaning ascribed to such term in Section 4.3(b). 


 


“Purchaser
Party” shall have the meaning ascribed to such term in Section 4.10.


 


“Registration
Rights Agreement” means the Registration Rights Agreement, dated the date hereof, among the Company and the Purchaser, in
the form of Exhibit B attached hereto.


 


“Registration
Statement” means the registration statement that the Company is required to file pursuant to this Agreement to register
the Conversion Shares, or as applicable, the Underlying Shares. The Registration Statement shall register all Conversion Shares,
or as applicable, the Underlying Shares, in connection with each Tranche.


 


“Required
Approvals” shall have the meaning ascribed to such term in Section 3.1(e).


 


“Required
Minimum” means, as of any date, the maximum aggregate number of shares of Common Stock then issued or potentially issuable
in the future pursuant to the Transaction Documents, including any Conversion Shares or Underlying Shares issuable upon conversion
in full of all Preferred Shares or all of the Notes, respectively and as the case may be (including Conversion Shares issuable
as payment of dividends, late-charges, make-whole amounts, and any other amounts described in the Certificate of Designations
and as applicable, Underlying Shares issuable as payment of interest on the Notes), ignoring any conversion or exercise limits
set forth therein, and assuming that the Conversion Price is at all times on and after the date of determination 100% of the then
Conversion Price on the Trading Day immediately prior to the date of determination. 


 


“Rule 144”
means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from time to time,
or any similar rule or regulation hereafter adopted by the Commission having substantially the same effect as such Rule.


 


“Rule
424” means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose
and effect as such Rule. 


 






    5


     

    

 


“SEC
Reports” shall have the meaning ascribed to such term in Section 3.1(h).


 


“Securities”
means the NACD Common Shares, the Preferred Shares and the Conversion Shares, and as applicable, the Notes and the Underlying
Shares. 


 


“Securities
Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder. 


 


“SEC
Effective   Date” means the date the Registration Statement is declared effective by the Commission. 


 


“Security
Agreement” means the Security and Pledge Agreement, dated the date hereof, among the Company and the Purchaser, in the form
of Exhibit C attached hereto.


 


“Security
Documents” shall mean the Security Agreement, the Collateral Assignment of Receivables, the Subsidiary Guarantees, the Validity
and Performance Guarantees, and the deposit account control agreement, in the form of Exhibit I attached hereto (the “Deposit
Account Control Agreement”), and any other documents and filing required thereunder in order to grant the Purchaser a first
priority security interest (or in the case of certain Collateral, a second priority security interest) in the assets of the Company
and the Subsidiaries as provided in the Security Agreement, including all UCC-1 filing receipts (it being agreed that as of the
date of execution of this Agreement, the Security Documents remain subject to final negotiation and execution in accordance with
the terms hereof). 


 


“Series
A Preferred Stock” means the Series A Convertible Preferred Stock, par value $0.001 per share, of the Company that can be
issued pursuant to the Certificate of Designations.


 


“Short
Sales” means all “short sales” as defined in Rule 200 of Regulation SHO under the Exchange Act. 


 


“Subscription
Amount” means, the aggregate amount to be paid for Preferred Shares (or as applicable, the Notes) purchased hereunder as
specified below the Purchaser’s name on the signature page of this Agreement and next to the heading “Subscription
Amount,” in United States dollars and in immediately available funds. 


 


“Subsidiary”
means any subsidiary of the Company as set forth on Schedule 3.1(a) and shall, where applicable, also include any direct
or indirect subsidiary of the Company formed or acquired after the date hereof. 


 


“Subsidiary
Guarantee” means the Subsidiary Guarantee, dated the date hereof, by each Subsidiary in favor of the Purchaser, in the form
of Exhibit D attached hereto.


 


“Trading
Day” means a day on which the principal Trading Market is open for trading. 


 






    6


     

    

 


“Trading
Market” means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the
date in question: the NYSE MKT; the Nasdaq Capital Market; the Nasdaq Global Market; the Nasdaq Global Select Market; the New
York Stock Exchange; the NYSE MKT, any level of the OTC Markets operated by OTC Markets Group, Inc. or the OTC Bulletin Board
(or any successors to any of the foregoing). 


 


“Tranche(s)”
shall have the meaning ascribed to such term in Section 2.1. 


 


“Transaction
Documents” means this Agreement, the Certificate of Designations, the Security Documents, the Registration Rights Agreement,
the Notes, the legal opinions of Company Counsel, the Transfer Agent Instruction Letter, all exhibits and schedules thereto and
hereto and any other documents or agreements executed in connection with the transactions contemplated hereunder. 


 


“Transfer
Agent” means Standard Registrar & Transfer Co. Inc., the current transfer agent of the Company, with a mailing address
of 12528 South 1840 Street, Draper, UT 84020 and a facsimile number of (801) 571-8844, and any successor transfer agent of the
Company. 


 


“Transfer
Agent Instruction Letter” means the letter from the Company to the Transfer Agent which instructs the Transfer Agent to
issue Conversion Shares, or as applicable, the Underlying Shares, pursuant to the Transaction Documents, in the form of Exhibit E
attached hereto. 


 


“Underlying
Shares” means the shares of Common Stock issued and issuable upon conversion or redemption of the Notes and issued and issuable
in lieu of the cash payment of interest on the Notes in accordance with the terms of the Notes.


 






    7


     

    

 


ARTICLE
II. 


PURCHASE
AND SALE; EXCHANGE


 


2.1
  Purchase.  


 


(a)The
Purchaser will purchase an aggregate of up to $1,500,000 in Subscription Amount corresponding to an aggregate of up to 1,578,948
shares (subject to Section 2.1(d)) of common stock of NACD (the “NACD Common Shares”). The purchase will occur in
up to ten (10) tranches of (each a “Tranche,” and collectively the “Tranches”), with the first Tranche
of $125,000 being funded to the Company upon execution of this Agreement (the “First Closing”). The second Tranche
will be for $125,000 and will be funded to the Company seven (7) days after the First Closing. The third Tranche will be for $125,000
and will be funded to the Company fourteen (14) days after the First Closing. The fourth Tranche will be for $125,000 and will
be funded to the Company twenty-one (21) days after the First Closing. The fifth Tranche will be for $125,000 and will be funded
to the Company twenty-eight (28) days after the First Closing. The sixth Tranche will be for $125,000 and will be funded to the
Company thirty-five (35) days after the First Closing. The seventh Tranche will be for $125,000 and will be funded to the Company
forty two (42) days after the First Closing. The eighth Tranche will be for $125,000 and will be funded to the Company forty-nine
(49) days after the First Closing. The ninth Tranche will be for $300,000 and will funded to the Company five (5) Business Days
following the filing by the Company with the Commission of the Company’s pending audit of its subsidiary Swiss Heights Engineering,
S.A. The tenth Tranche will be for $200,000 and will funded to the Company five (5) Business Days after the effectiveness of the
Registration Statement. 


 


(b)The
Purchaser shall not be required to fund any of the second through tenth Tranches if: (i) the Company, its Subsidiaries, or any
of the directors or officers of the Company or its Subsidiaries commit fraud; (ii) the Company or its Subsidiaries breach any
covenant contained herein or in the other Transaction Documents in any material respect and such covenant breach is not cured
within five (5) days of written notice therefor from the Purchase to the Company (or as applicable, NACD); (iii) if a Trigger
Event (as defined in the Certificate of Designations) is in effect on any such Closing Dates; provided that the Company shall
have five (5) days from the applicable Tranche date of funding to cure any such Triggering Event; or (iv) the deliverables required
at the First Closing are not executed and delivered by November 11, 2016 (as described in Section 2.3(c).


 


(c)In
addition, notwithstanding the foregoing, (i) upon the effectiveness of the Registration Statement, the Purchaser shall have the
option to fund an additional $1,000,000 in the form of Preferred Shares (or, if the Preferred Shares are not then authorized and
effective, in the form of a Note) on substantially the same terms and conditions as contained in this Agreement, which funding
shall be deemed a separate offering and be memorialized pursuant to separate documentation substantially similar to this Agreement
and the other Transaction Documents, and (ii) the Company and the Purchaser may accelerate the payment of any of the second through
tenth tranches by mutual written consent.


 


(d)Notwithstanding
anything to the contrary contained herein, NACD shall issue to the Purchaser at the First Closing 1,578,948 NACD Common Shares
(which shall be exchanged for the Preferred Shares as set forth in Section 2.5 herein).


 


2.2
  Closing.  On each Closing Date, upon the terms and subject to the conditions set forth herein, substantially
concurrent with the execution and delivery of this Agreement by the parties hereto, NACD (or the Company, as applicable) agrees
to sell, and the Purchaser, agrees to purchase, the Purchaser’s Closing Subscription Amount as set forth on the signature
page hereto executed by the Purchaser (an aggregate of up to $1,500,000 in Subscription Amount corresponding to an aggregate of
up to 1,578,948 NACD Common Shares (subject to Section 2.1(d)).  At each Closing, the Purchaser shall deliver to the
Company, via wire transfer to an account designated by the Company, immediately available funds equal to the Purchaser’s
Subscription Amount as set forth in Section 2.1, and the Company, if applicable, shall deliver to the Purchaser the Preferred
Shares, as determined pursuant to Section 2.3(a) and Section 2.5, and the Company and the Purchaser shall deliver the other
items set forth in Section 2.3 deliverable at the First Closing.  Upon satisfaction of the covenants and conditions
set forth in Sections 2.3 and 2.4 for each Closing, each Closing shall occur at the offices of Ellenoff Grossman & Schole
LLP or such other location as the parties shall mutually agree, and may by agreement be undertaken remotely by electronic exchange
of Closing documentation.


 






    8


     

    

 


2.3
  Deliveries.


 


(a)
  On or prior to each Closing Date (except as noted), the Company (or as applicable, NACD) shall deliver or cause to be delivered
to the Purchaser the following:


 


(i)  
as to the First Closing, this Agreement duly executed by the Company and NACD;


 


(ii)
 the legal opinions of Company Counsel, substantially in form and substance reasonably acceptable to Purchaser’s counsel,
with such legal opinions being issued as follows: (A) upon the execution and delivery of the Transaction Documents required to
be executed and delivered on the First Closing (or at the latest, November 11, 2016, in accordance with Section 2.3(c)), a legal
opinion with respect to such Transaction Documents and the issuance of the NACD Common Shares; and (B) upon the authorization
of the Preferred Shares, a legal opinion with respect to the issuance of the Preferred Shares (or as applicable, the Notes));


 


(iii)
 the Transfer Agent Instruction Letter duly executed by the Company and the Transfer Agent; 


 


(iv)
 as to the First Closing, NACD shall issue to the Purchaser the NACD Common Shares, registered in the name of the Purchaser;



 


(v)
as to the First Closing, the Registration Rights Agreement, duly executed by the Company;


 


(vi)
as to the First Closing, the Security Agreement, duly executed by the Company and each Subsidiary, along with the other Security
Documents, including the Subsidiary Guarantee, the Collateral Assignment of Receivables, and the Performance Guarantees, the Deposit
Account Control Agreement, and the Assignment of the Letter of Credit, duly executed by the parties thereto; and


 


(vii)
subject to section 2.5, the requisite amount of Preferred Shares equal to the applicable Tranche amount as of the applicable Closing,
registered in the name of the Purchaser.


 


(b)
  On or prior to the applicable Closing Date, the Purchaser shall deliver or cause to be delivered to the Company, as applicable,
the following:


 


(i)
  as to the First Closing, this Agreement duly executed by the Purchaser; 


 






    9


     

    

 


(ii)
the Purchaser’s Subscription Amount as to the applicable Closing by wire transfer to the account specified in writing by
the Company; 


 


(iii)
as to the First Closing, the Registration Rights Agreement, duly executed by the Purchaser; and 


 


(iv)
as to the First Closing, the Security Agreement, the Collateral Assignment of Receivables, and the Performance Guarantees, duly
executed by the Purchaser.


 


(c)
  With respect to the First Closing, in the event that any of the deliverables set forth in Section 2.3(a)-(b) cannot be
delivered on the date hereof due to the fact that the parties have not reached final agreement with respect thereto (with the
exception of the delivery of this Agreement by the Purchaser, the Company, and NACD, and the issuance of the NACD Common Shares
to the Purchaser by NACD; all of which must be delivered on the date hereof), such deliverables shall be delivered on or before
November 11, 2016. In the event that such deliverables are not delivered on or before November 11, 2016, the Company shall pay
a break-up fee of USD$75,000 to the Purchaser in immediately available funds on or before November 17, 2016; provided, however,
that the Break-Up Fee shall not be due and payable to Purchaser if the deliverables (including the items requested by Purchaser
as called for in the agreements comprising such deliverables) (i) are not delivered due to bad faith negotiating or malicious
intent on the part of the Purchaser or (ii) cannot be delivered by the Company after having
made repeated reasonable and good faith efforts and has concluded as a result of such efforts that its inability to effect such
deliverable is due to circumstances beyond the control of the Company (such as inalienable legal requirements in non-U.S. jurisdictions)
or without material extra costs being incurred by the Company or its Subsidiaries, which in each case are not commercially reasonable;
and provided, further, however, that no decision as to the materiality of such costs may be made without consulting with
the Purchaser, which shall have the right, but not the obligation, to contribute to such costs on terms memorialized on Schedule
2.3(c).


 


2.4
  Closing Conditions.


 


(a)
  The obligations of the Company hereunder in connection with each Closing are subject to the following conditions being
met:


 


(i)
 the accuracy in all material respects on the applicable Closing Date of the representations and warranties of the Purchaser
contained herein (unless as of a specific date therein in which case they shall be accurate as of such date);


 


(ii)
 all obligations, covenants and agreements of the Purchaser required to be performed at or prior to the applicable Closing
Date shall have been performed; and


 


(iii)
 the delivery by the Purchaser of the items set forth in Section 2.3(b) of this Agreement (subject to Section 2.3(c)).


 






    10


     

    

 


(b)
  The respective obligations of the Purchaser hereunder in connection with each Closing are subject to the following conditions
being met:


 


(i)
  the accuracy in all material respects when made and on the applicable Closing Date of the representations and warranties
of the Company (and as applicable, NACD) contained herein (unless as of a specific date therein);


 


(ii)
 all obligations, covenants and agreements of the Company (and as applicable, NACD) required to be performed at or prior
to the applicable Closing Date shall have been performed;


 


(iii)
 the delivery by the Company (and as applicable, NACD) of the items set forth in Section 2.3(a) of this Agreement (subject
to Section 2.3(c));


 


(iv)
  there is no Triggering Event (as defined in the Certificate of Designations); 


 


(v)
there is no material breach of this Agreement, including, without limitation, a breach of the covenants set forth in Sections
2.3(c) and 4.16 herein;


 


(vi)
  there shall have been no Material Adverse Effect with respect to the Company (and as applicable, NACD) since the date hereof;
and


  


(vi)
  from the date hereof to the applicable Closing Date, trading in the Common Stock shall not have been suspended by the Commission  or
the Company’s principal Trading Market and, at any time prior to the applicable Closing Date, trading in securities generally
as reported by Bloomberg L.P. shall not have been suspended or limited, or minimum prices shall not have been established on securities
whose trades are reported by such service, or on any Trading Market, nor shall a banking moratorium have been declared either
by the United States or New York State authorities nor shall there have occurred any material outbreak or escalation of hostilities
or other national or international calamity of such magnitude in its effect on, or any material adverse change in, any financial
market which, in each case, in the reasonable judgment of the Purchaser, and without regard to any factors unique to the Purchaser,
makes it impracticable or inadvisable to purchase the Securities at the applicable Closing.


 


		2.5	Exchange;
                                         Forfeiture; Issuance of Notes. 



 


(a)
Upon the filing and effectiveness of the Certificate of Designations with the Secretary of State of the State of Nevada, the Purchaser
shall automatically exchange the NACD Common Shares for a like number of the Preferred Shares, and the Company shall to issue
the Preferred Shares in exchange for the NACD Common Shares, all on the terms and conditions set forth in this Section 2.5.


 






    11


     

    

 


(b)
Subject to and upon the terms and conditions set forth in this Agreement, the Purchaser agrees to
surrender to the Company the requisite pro-rata portion of the NACD Common Shares and, in exchange therefore, the Company shall
issue to the Purchaser the requisite pro-rata portion of the Preferred Shares (each, an “Exchange”). Within one (1)
day of the filing of the Certificate of Designations with the Secretary of State of the State of Nevada, the Company will issue
and deliver (or cause to be issued and delivered) the Preferred Shares to the Purchaser, or in the name of a custodian or nominee
of the Purchaser, or as otherwise requested by the Purchaser in writing, and the Purchaser will surrender to the Company an equal
amount of the NACD Common Shares. For the avoidance of doubt, one (1) NACD Common Share shall be exchangeable for one (1) Preferred
Share.


 


(c)
Assuming the accuracy of the representations and warranties of each of the Company, NACD, and the Purchaser set forth in Section
3 of this Agreement, the parties acknowledge and agree that the purpose of such representations and warranties is, among other
things, to ensure that the Exchange qualifies as a private exchange of securities under Sections 4(a)(2) and 3(a)(9) of the Securities
Act, for no additional consideration.


 


(d)
The Company and NACD each acknowledge and agree that any representations and warranties contained in Section 3 herein with respect
to the NACD Common Shares, shall also apply to the Preferred Shares and the Conversion Shares, respectively. 


 


(e)
The Company acknowledges that in the event that the filing of the Certificate of Designations with the Secretary of State of the
State of Nevada has not occurred by December 9, 2016, then, the Company shall issue to the Purchaser, in lieu of Preferred shares,
Notes (containing substantially similar terms and conditions to those contained in the Certificate of Designations) in the aggregate
subscription amount of the Tranches actually funded by Purchaser as of such date in accordance with the purchase schedule set
forth in Section 2.1 hereto, all on the terms and conditions set forth in this Agreement. In such event, the Purchaser may demand
that the Company enters into a separate securities purchase agreement with the Purchaser with respect to the sale and issuance
of such Notes, which agreement shall be in a form and substance similar to this Agreement (including substantially similar representations
and warranties). The Company acknowledges and agrees that any representations and warranties contained in Section 3 herein with
respect to the Preferred Shares and the Conversion Shares, shall also apply to the Notes and the Underlying Shares, respectively.
Notwithstanding the foregoing, in the event that the Commission provides comments to the related Preliminary Information Statement
on Schedule 14C, the Company shall have until December 30, 2016 to file the Certificate of Designations with the Secretary of
State of the State of Nevada.


 


(f)
In the event that one or more Tranches are not funded by Purchaser as required in Section 2.1(a) (subject to the Purchaser’s
rights to withhold the funding of any Tranches as set forth in Section 2.1(b)), then a pro-rata portion (corresponding to the
amount of the unfunded Tranches) of the NACD Common Shares shall, without any further action required of the Purchaser, NACD or
the Company (i) be automatically forfeited by the Purchaser and cancelled by NACD and (ii) no longer be outstanding for any purpose,
and Purchaser shall forfeit any rights with respect to the forfeited NACD Common Shares under this Agreement, under any Transaction
Document, or under applicable law. For the avoidance of doubt, the pro-rata portion of the NACD Common Shares shall only be subject
to forfeiture and cancellation in the event that the Purchaser does not fund one or more Tranches due to a reason that is not
set forth in Section 2.1(b) or as otherwise described in this Agreement.


 






    12


     

    

 


ARTICLE
III. 


REPRESENTATIONS
AND WARRANTIES 


 


3.1
  Representations and Warranties of the Company and NACD.  Except as set forth in the Disclosure Schedules,
which Disclosure Schedules shall be deemed a part hereof and shall qualify any representation or otherwise made herein to the
extent of the disclosure contained in the corresponding section of the Disclosure Schedules, the Company hereby makes the following
representations and warranties to the Purchaser as of the date hereof (and to the extent applicable, NACD hereby makes the following
representations and warranties to the Purchaser with respect to itself only):


 


(a)
  Subsidiaries.  All of the direct and indirect subsidiaries of the Company are set forth on Schedule 3.1(a).
The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear
of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully
paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no
subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.


 


(b)
  Organization and Qualification. The Company and each of the Subsidiaries is an entity duly incorporated or otherwise
organized, validly existing and in good standing under the laws of the jurisdiction of its incorporation or organization, with
the requisite power and authority to own and use its properties and assets and to carry on its business as currently conducted.
Neither the Company nor any Subsidiary is in violation nor default of any of the provisions of its respective certificate or articles
of incorporation, bylaws or other organizational or charter documents. Each of the Company and the Subsidiaries is duly qualified
to conduct business and is in good standing as a foreign corporation or other entity in each jurisdiction in which the nature
of the business conducted or property owned by it makes such qualification necessary, except where the failure to be so qualified
or in good standing, as the case may be, could not have or reasonably be expected to result in: (i) a material adverse effect
on the legality, validity or enforceability of any Transaction Document; (ii) a material adverse effect on the results of
operations, assets, business, prospects or condition (financial or otherwise) of the Company and the Subsidiaries, taken as a
whole; or (iii) a material adverse effect on the Company’s ability to perform in any material respect on a timely basis
its obligations under any Transaction Document (any of (i), (ii) or (iii), a “Material Adverse Effect”) and no Proceeding
has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking to revoke, limit or curtail such power
and authority or qualification.


  






    13


     

    

 


(c)
  Authorization; Enforcement.  The Company has the requisite corporate power and authority to enter into
and to consummate the transactions contemplated by this Agreement and each of the other Transaction Documents and otherwise to
carry out its obligations hereunder and thereunder.  The execution and delivery of this Agreement and each of the other
Transaction Documents by the Company and the consummation by it of the transactions contemplated hereby and thereby have been
duly authorized by all necessary action on the part of the Company and no further action is required by the Company, the Board
of Directors or the Company’s stockholders in connection herewith or therewith other than in connection with the Required
Approvals.  This Agreement and each other Transaction Document to which it is a party has been (or upon delivery will
have been) duly executed by the Company and, when delivered in accordance with the terms hereof and thereof, will constitute the
valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except: (i) as
limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general
application affecting enforcement of creditors’ rights generally; (ii) as limited by laws relating to the availability
of specific performance, injunctive relief or other equitable remedies; and (iii) insofar as indemnification and contribution
provisions may be limited by applicable law.


 


(d)
  No Conflicts.  The execution, delivery and performance by the Company of this Agreement and the other
Transaction Documents to which it is a party, the issuance and sale of the Securities and the consummation by it of the transactions
contemplated hereby and thereby do not and will not: (i) conflict with or violate any provision of the Company’s or
any Subsidiary’s certificate or articles of incorporation, bylaws or other organizational or charter documents; (ii) conflict
with, or constitute a default (or an event that with notice or lapse of time or both would become a default) under, result in
the creation of any Lien (except Liens in favor of the Purchaser) upon any of the properties or assets of the Company or any Subsidiary,
or give to others any rights of termination, amendment, acceleration or cancellation (with or without notice, lapse of time or
both) of, any agreement, credit facility, debt or other instrument (evidencing a Company or Subsidiary debt or otherwise) or other
understanding to which the Company or any Subsidiary is a party or by which any property or asset of the Company or any Subsidiary
is bound or affected; or (iii) subject to the Required Approvals, conflict with or result in a violation of any law, rule,
regulation, order, judgment, injunction, decree or other restriction of any court or governmental authority to which the Company
or a Subsidiary is subject (including federal and state securities laws and regulations), or by which any property or asset of
the Company or a Subsidiary is bound or affected; except in the case of each of clauses (ii) and (iii), such as could not
have or reasonably be expected to result in a Material Adverse Effect.


  



(e)
  Filings, Consents and Approvals.  The Company is not required to obtain any consent, waiver, authorization
or order of, give any notice to, or make any filing or registration with, any court or other federal, state, local or other governmental
authority or other Person in connection with the execution, delivery and performance by the Company of the Transaction Documents,
other than: (i) the filings required pursuant to Section 4.6 of this Agreement, (ii) the notice and/or application(s)
to each applicable Trading Market for the issuance and sale of the Securities and the listing of the Conversion Shares (and as
applicable, the Underlying Shares) for trading thereon in the time and manner required thereby and (iii) the filing of Form
D with the Commission and such filings as are required to be made under applicable state securities laws (collectively, the “Required
Approvals”).


 






    14


     

    

 


(f)
  Issuance of the Securities.  The Securities are duly authorized and, when issued and paid for in accordance
with the applicable Transaction Documents, will be duly and validly issued, fully paid and nonassessable, free and clear of all
Liens imposed by the Company other than restrictions on transfer provided for in the Transaction Documents.  The Conversion
Shares and the Underlying Shares, when issued in accordance with the terms of the Transaction Documents, will be validly issued,
fully paid and nonassessable, free and clear of all Liens imposed by the Company other than restrictions on transfer provided
for in the Transaction Documents.


 


(g)
  Capitalization.  The capitalization of the Company is as set forth on Schedule 3.1(g), which Schedule 3.1(g)
shall also include the number of shares of Common Stock owned beneficially, and of record, by Affiliates of the Company as of
the date hereof. The Company has not issued any capital stock since its most recently filed periodic report under the Exchange
Act, the issuance of shares of Common Stock to employees pursuant to the Company’s employee stock purchase plans and pursuant
to the conversion and/or exercise of Common Stock Equivalents outstanding as of the date of the most recently filed periodic report
under the Exchange Act.   No Person has any right of first refusal, preemptive right, right of participation, or any
similar right to participate in the transactions contemplated by the Transaction Documents. There are no outstanding options,
warrants, scrip rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities, rights or
obligations convertible into or exercisable or exchangeable for, or giving any Person any right to subscribe for or acquire any
shares of Common Stock, or contracts, commitments, understandings or arrangements by which the Company or any Subsidiary is or
may become bound to issue additional shares of Common Stock or Common Stock Equivalents.  The issuance and sale of the Securities
will not obligate the Company to issue shares of Common Stock or other securities to any Person (other than the Purchaser) and
will not result in a right of any holder of Company securities to adjust the exercise, conversion, exchange or reset price under
any of such securities. All of the outstanding shares of capital stock of the Company are duly authorized, validly issued, fully
paid and nonassessable, have been issued in compliance with all federal and state securities laws, and none of such outstanding
shares was issued in violation of any preemptive rights or similar rights to subscribe for or purchase securities.  No
further approval or authorization of any stockholder, the Board of Directors or others is required for the issuance and sale of
the Securities.  There are no stockholders agreements, voting agreements or other similar agreements with respect to
the Company’s capital stock to which the Company is a party or, to the knowledge of the Company, between or among any of
the Company’s stockholders.


 






    15


     

    

 


(h)
  SEC Reports; Financial Statements.  Except for the Company’s pending audit of Swiss Heights Engineering
S.A., the Company has filed all reports, schedules, forms, statements and other documents required to be filed by the Company
under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the two years preceding
the date hereof (or such shorter period as the Company was required by law or regulation to file such material) (the foregoing
materials, including the exhibits thereto and documents incorporated by reference therein, being collectively referred to herein
as the “SEC Reports”).  As of their respective dates, the SEC Reports complied in all material respects
with the requirements of the Securities Act and the Exchange Act, as applicable, and none of the SEC Reports, when filed, contained
any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order
to make the statements therein, in the light of the circumstances under which they were made, not misleading.  The Company
has never been an issuer subject to Rule 144(i) under the Securities Act. The financial statements of the Company included
in the SEC Reports comply in all material respects with applicable accounting requirements and the rules and regulations of the
Commission with respect thereto as in effect at the time of filing.  Such financial statements have been prepared in
accordance with United States generally accepted accounting principles applied on a consistent basis during the periods involved
(“GAAP”), except as may be otherwise specified in such financial statements or the notes thereto and except that unaudited
financial statements may not contain all footnotes required by GAAP, and fairly present in all material respects the financial
position of the Company and its consolidated Subsidiaries as of and for the dates thereof and the results of operations and cash
flows for the periods then ended, subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments.



 


(i)
Material Changes; Undisclosed Events, Liabilities or Developments.  Since the date of the latest audited financial
statements included within the SEC Reports, except as specifically disclosed in a subsequent SEC Report filed prior to the date
hereof: (i) there has been no event, occurrence or development that has had or that could reasonably be expected to result
in a Material Adverse Effect; (ii) the Company has not incurred any liabilities (contingent or otherwise) other than (A) trade
payables and accrued expenses incurred in the ordinary course of business consistent with past practice and (B) liabilities
not required to be reflected in the Company’s financial statements pursuant to GAAP or disclosed in filings made with the
Commission; (iii) the Company has not altered its method of accounting; (iv) the Company has not declared or made any
dividend or distribution of cash or other property to its stockholders or purchased, redeemed or made any agreements to purchase
or redeem any shares of its capital stock; and (v) the Company has not issued any equity securities to any officer, director or
Affiliate. Except for the issuance of the Securities contemplated by this Agreement, no event, liability, fact, circumstance,
occurrence or development has occurred or exists or is reasonably expected to occur or exist with respect to the Company or its
Subsidiaries or their respective businesses, properties, operations, assets or financial condition, that would be required to
be disclosed by the Company under applicable securities laws at the time this representation is made or deemed made that has not
been publicly disclosed at least 1 Trading Day prior to the date that this representation is made. 


 






    16


     

    

 


(j)
  Litigation.  Except as set forth on Schedule 3.1(j), there is no action, suit, inquiry, notice of violation,
proceeding or investigation pending or, to the knowledge of the Company, threatened against or affecting the Company, any Subsidiary
or any of their respective properties before or by any court, arbitrator, governmental or administrative agency or regulatory
authority (federal, state, county, local or foreign) (collectively, an “Action”) which (i) adversely affects
or challenges the legality, validity or enforceability of any of the Transaction Documents or the Securities or (ii) could,
if there were an unfavorable decision, have or reasonably be expected to result in a Material Adverse Effect, and neither the
Company nor any Subsidiary, nor any director or officer thereof, is or has been the subject of any Action involving a claim of
violation of or liability under federal or state securities laws or a claim of breach of fiduciary duty.  There has
not been, and to the knowledge of the Company, there is not pending or contemplated, any investigation by the Commission involving
the Company or any current or former director or officer of the Company that is likely to lead to action that can reasonably be
expected to result in a Material Adverse Effect. There has not been, and to the knowledge of the Company, there is not pending
or contemplated, any investigation by the Commission involving the Company or any current or former director or officer of the
Company.   The Commission has not issued any stop order or other order suspending the effectiveness of any registration
statement filed by the Company or any Subsidiary under the Exchange Act or the Securities Act.


 


(k)
  Labor Relations.  No labor dispute exists or, to the knowledge of the Company, is imminent with respect
to any of the employees of the Company, which could reasonably be expected to result in a Material Adverse Effect. None of the
Company’s or its Subsidiaries’ employees is a member of a union that relates to such employee’s relationship
with the Company or such Subsidiary, and except as set forth Schedule 3.1(k), neither the Company nor any of its Subsidiaries
is a party to a collective bargaining agreement, and the Company and its Subsidiaries believe that their relationships with their
employees are good in all material respects. To the knowledge of the Company, no executive officer of the Company or any Subsidiary,
is, or is now expected to be, in violation of any material term of any employment contract, confidentiality, disclosure or proprietary
information agreement or non-competition agreement, or any other contract or agreement or any restrictive covenant in favor of
any third party, and the continued employment of each such executive officer does not subject the Company or any of its Subsidiaries
to any liability with respect to any of the foregoing matters.  The Company and its Subsidiaries are in compliance with
all U.S. federal, state, local and foreign laws and regulations relating to employment and employment practices, terms and conditions
of employment and wages and hours, except where the failure to be in compliance could not, individually or in the aggregate, reasonably
be expected to have a Material Adverse Effect.


 






    17


     

    

 


(l)
  Compliance.  Neither the Company nor any Subsidiary: (i) is in default under or in violation of (and
no event has occurred that has not been waived that, with notice or lapse of time or both, would result in a default by the Company
or any Subsidiary under), nor has the Company or any Subsidiary received notice of a claim that it is in default under or that
it is in violation of, any indenture, loan or credit agreement or any other agreement or instrument to which it is a party or
by which it or any of its properties is bound (whether or not such default or violation has been waived), (ii) is in violation
of any judgment, decree or order of any court, arbitrator or other governmental authority or (iii) is or has been in violation
of any statute, rule, ordinance or regulation of any governmental authority, including without limitation all foreign, federal,
state and local laws relating to taxes, environmental protection, occupational health and safety, product quality and safety and
employment and labor matters, except in each case as could not have or reasonably be expected to result in a Material Adverse
Effect.


  



(m)
  Regulatory Permits.  The Company and the Subsidiaries possess all certificates, authorizations and permits
issued by the appropriate federal, state, local or foreign regulatory authorities necessary to conduct their respective businesses
as described in the SEC Reports, except where the failure to possess such permits could not reasonably be expected to result in
a Material Adverse Effect (“Material Permits”), and neither the Company nor any Subsidiary has received any notice
of proceedings relating to the revocation or modification of any Material Permit.


 


(n)
  Title to Assets.  The Company and the Subsidiaries have good and marketable title in fee simple to all
real property owned by them and good and marketable title in all personal property owned by them that is material to the business
of the Company and the Subsidiaries, in each case free and clear of all Liens, except for (i) Liens as do not materially
affect the value of such property and do not materially interfere with the use made and proposed to be made of such property by
the Company and the Subsidiaries and (ii) Liens for the payment of federal, state or other taxes, for which appropriate reserves
have been made therefor in accordance with GAAP and, the payment of which is neither delinquent nor subject to penalties. Any
real property and facilities held under lease by the Company and the Subsidiaries are held by them under valid, subsisting and
enforceable leases with which the Company and the Subsidiaries are in compliance.


 


(o)
  Intellectual Property.  The Company and the Subsidiaries have, or have rights to use, all patents, patent
applications, trademarks, trademark applications, service marks, trade names, trade secrets, inventions, copyrights, licenses
and other intellectual property rights and similar rights as described in the SEC Reports as necessary or required for use in
connection with their respective businesses as presently conducted and which the failure to so have could have a Material Adverse
Effect (collectively, the “Intellectual Property Rights”). None of, and neither the Company nor any Subsidiary has
received a notice (written or otherwise) that any of, the Intellectual Property Rights has expired, terminated or been abandoned,
or is expected to expire or terminate or be abandoned, within two (2) years from the date of this Agreement.  Neither
the Company nor any Subsidiary has received, since the date of the latest audited financial statements included within the SEC
Reports, a written notice of a claim or otherwise has any knowledge that the Intellectual Property Rights violate or infringe
upon the rights of any Person, except as could not have or reasonably be expected to not have a Material Adverse Effect. To the
knowledge of the Company, all such Intellectual Property Rights are enforceable and there is no existing infringement by another
Person of any of the Intellectual Property Rights. The Company and its Subsidiaries have taken reasonable security measures to
protect the secrecy, confidentiality and value of all of their intellectual properties, except where failure to do so could not,
individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.


 






    18


     

    

 


(p)
  Transactions with Affiliates and Employees.  Except as set forth on Schedule 3.1(p), none of the officers
or directors of the Company or any Subsidiary and, to the knowledge of the Company, none of the employees of the Company or any
Subsidiary is presently a party to any transaction with the Company or any Subsidiary (other than for services as employees, officers
and directors), including any contract, agreement or other arrangement providing for the furnishing of services to or by, providing
for rental of real or personal property to or from providing for the borrowing of money from or lending of money to, or otherwise
requiring payments to or from any officer, director or such employee or, to the knowledge of the Company, any entity in which
any officer, director, or any such employee has a substantial interest or is an officer, director, trustee, stockholder, member
or partner, in each case in excess of $120,000 other than for: (i) payment of salary or consulting fees for services rendered;
(ii) reimbursement for expenses incurred on behalf of the Company; and (iii) other employee benefits. 


 


(q)
  Sarbanes-Oxley; Internal Accounting Controls.  Except as set forth on Schedule 3.1(q), the Company and the
Subsidiaries are in material compliance with any and all applicable requirements of the Sarbanes-Oxley Act of 2002 that are effective
as of the date hereof, and any and all applicable rules and regulations promulgated by the Commission thereunder that are effective
as of the date hereof and as of the applicable Closing Date. The Company and the Subsidiaries maintain a system of internal accounting
controls sufficient to provide reasonable assurance that: (i) transactions are executed in accordance with management’s
general or specific authorizations; (ii) transactions are recorded as necessary to permit preparation of financial statements
in conformity with GAAP and to maintain asset accountability; (iii) access to assets is permitted only in accordance with
management’s general or specific authorization; and (iv) the recorded accountability for assets is compared with the
existing assets at reasonable intervals and appropriate action is taken with respect to any differences. The Company and the Subsidiaries
have established disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Company
and the Subsidiaries and designed such disclosure controls and procedures to ensure that information required to be disclosed
by the Company in the reports it files or submits under the Exchange Act is recorded, processed, summarized and reported, within
the time periods specified in the Commission’s rules and forms. The Company’s certifying officers have evaluated the
effectiveness of the disclosure controls and procedures of the Company and the Subsidiaries as of the end of the period covered
by the most recently filed periodic report under the Exchange Act (such date, the “Evaluation Date”).  The
Company presented in its most recently filed periodic report under the Exchange Act the conclusions of the certifying officers
about the effectiveness of the disclosure controls and procedures based on their evaluations as of the Evaluation Date.  Since
the Evaluation Date, there have been no changes in the internal control over financial reporting (as such term is defined in the
Exchange Act) that have materially affected, or is reasonably likely to materially affect, the internal control over financial
reporting of the Company and its Subsidiaries.


 






    19


     

    

 


(r)
  Certain Fees.  Other than as set forth on Schedule 3.1(r), no brokerage or finder’s fees or
commissions are or will be payable by the Company or any Subsidiaries to any broker, financial advisor or consultant, finder,
placement agent, investment banker, bank or other Person with respect to the transactions contemplated by the Transaction Documents.  The
Purchaser shall have no obligation with respect to any fees or with respect to any claims made by or on behalf of other Persons
for fees of a type contemplated in this Section that may be due in connection with the transactions contemplated by the Transaction
Documents.


  


(s)
  Private Placement.  Assuming the accuracy of the Purchaser’s representations and warranties set
forth in Section 3.2, no registration under the Securities Act is required for the offer and sale of the Securities by the Company
to the Purchaser as contemplated hereby. The issuance and sale of the Securities hereunder does not contravene the rules and regulations
of the Trading Market.


 


(t)
  Investment Company. The Company is not, and is not an Affiliate of, and immediately after receipt of payment for
the Securities, will not be or be an Affiliate of, an “investment company” within the meaning of the Investment Company
Act of 1940, as amended.  The Company shall conduct its business in a manner so that it will not become an “investment
company” subject to registration under the Investment Company Act of 1940, as amended.


 


(u)
  Registration Rights.  Other than the Purchaser, no Person has any right to cause the Company to effect
the registration under the Securities Act of any securities of the Company or any Subsidiaries.


 


(v)
  Listing and Maintenance Requirements.  The Common Stock is registered pursuant to Section 12(b) or
12(g) of the Exchange Act, and the Company has taken no action designed to, or which to its knowledge is likely to have the effect
of, terminating the registration of the Common Stock under the Exchange Act nor has the Company received any notification that
the Commission is contemplating terminating such registration.  The Company has not, in the twelve (12) months preceding
the date hereof, received notice from any Trading Market on which the Common Stock is or has been listed or quoted to the effect
that the Company is not in compliance with the listing or maintenance requirements of such Trading Market. The Company is, and
has no reason to believe that it will not in the foreseeable future continue to be, in compliance with all such listing and maintenance
requirements.


 


(w)
  Application of Takeover Protections.  The Company and the Board of Directors have taken all necessary
action, if any, in order to render inapplicable any control share acquisition, business combination, poison pill (including any
distribution under a rights agreement) or other similar anti-takeover provision under the Company’s Articles of Incorporation
(or similar charter documents) or the laws of its state of incorporation that is or could become applicable to the Purchaser as
a result of the Purchaser and the Company fulfilling their obligations or exercising their rights under the Transaction Documents,
including without limitation as a result of the Company’s issuance of the Securities and the Purchaser’s ownership
of the Securities.


 






    20


     

    

 


(x)
  Disclosure.  Following the filing by the Company with the Commission of the Company’s pending audit
of Swiss Heights Engineering S.A., the Company confirms that neither it nor any other Person acting on its behalf has provided
the Purchaser or their agents or counsel with any information that it believes constitutes or might constitute material, non-public
information. The Company understands and confirms that the Purchaser will rely on the foregoing representation in effecting transactions
in securities of the Company.  All of the disclosure furnished by or on behalf of the Company to the Purchaser regarding
the Company and its Subsidiaries, their respective businesses and the transactions contemplated hereby, including the Disclosure
Schedules to this Agreement, is true and correct and does not contain any untrue statement of a material fact or omit to state
any material fact necessary in order to make the statements made therein, in light of the circumstances under which they were
made, not misleading. The Company acknowledges and agrees that the Purchaser does not make or has not made any representations
or warranties with respect to the transactions contemplated hereby other than those specifically set forth in Section 3.2
hereof.


 


(y)
  No Integrated Offering. Assuming the accuracy of the Purchaser’s representations and warranties set forth
in Section 3.2, neither the Company, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly
or indirectly, made any offers or sales of any security or solicited any offers to buy any security, under circumstances that
would cause this offering of the Securities to be integrated with prior offerings by the Company for purposes of (i) the
Securities Act which would require the registration of any such securities under the Securities Act, or (ii) any applicable
shareholder approval provisions of any Trading Market on which any of the securities of the Company are listed or designated.


 


(z)
  No General Solicitation. Neither the Company nor any person acting on behalf of the Company has offered or sold
any of the Securities by any form of general solicitation or general advertising. The Company has offered the Securities for sale
only to the Purchaser and certain other “accredited investors” within the meaning of Rule 501 under the Securities
Act.


 


(aa)
  Foreign Corrupt Practices.  Neither the Company nor any Subsidiary, nor to the knowledge of the Company
or any Subsidiary, any agent or other person acting on behalf of the Company or any Subsidiary, has: (i) directly or indirectly,
used any funds for unlawful contributions, gifts, entertainment or other unlawful expenses related to foreign or domestic political
activity; (ii) made any unlawful payment to foreign or domestic government officials or employees or to any foreign or domestic
political parties or campaigns from corporate funds; (iii) failed to disclose fully any contribution made by the Company
or any Subsidiary (or made by any person acting on its behalf of which the Company is aware) which is  in violation
of law; or (iv) violated in any material respect any provision of FCPA.


 






    21


     

    

 


(bb)
  Accountants.  The Company’s accounting firm is set forth on Schedule 3.1(bb) of the Disclosure
Schedules.  To the knowledge and belief of the Company, such accounting firm is a registered public accounting firm
as required by the Exchange Act.


 


(cc)
  No Disagreements with Accountants and Lawyers.  There are no disagreements of any kind presently existing,
or reasonably anticipated by the Company to arise, between the Company and the accountants and lawyers formerly or presently employed
by the Company and the Company is current with respect to any fees owed to its accountants and lawyers which could affect the
Company’s ability to perform any of its obligations under any of the Transaction Documents.


 


(dd)
  Acknowledgment Regarding Purchaser’s Purchase of Securities.   The Company acknowledges and agrees
that the Purchaser is acting solely in the capacity of an arm’s length purchaser with respect to the Transaction Documents
and the transactions contemplated thereby. The Company further acknowledges that the Purchaser is not acting as a financial advisor
or fiduciary of the Company (or in any similar capacity) with respect to the Transaction Documents and the transactions contemplated
thereby and any advice given by the Purchaser or any of its representatives or agents in connection with the Transaction Documents
and the transactions contemplated thereby is merely incidental to the Purchaser’s purchase of the Securities. The Company
further represents to the Purchaser that the Company’s decision to enter into this Agreement and the other Transaction Documents
has been based solely on the independent evaluation of the transactions contemplated hereby by the Company and its representatives.


  


(ee)
  Regulation M Compliance.  The Company has not, and to its knowledge no one acting on its behalf has, (i) taken,
directly or indirectly, any action designed to cause or to result in the stabilization or manipulation of the price of any security
of the Company to facilitate the sale or resale of any of the Securities, (ii) sold, bid for, purchased, or paid any compensation
for soliciting purchases of, any of the Securities, or (iii) paid or agreed to pay to any Person any compensation for soliciting
another to purchase any other securities of the Company, other than, in the case of clauses (ii) and (iii), compensation paid
to the Company’s placement agent in connection with the placement of the Securities.


 


(ff)
  Reserved.


 


(gg)
  Office of Foreign Assets Control.  Neither the Company nor any Subsidiary nor, to the Company's knowledge,
any director, officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions
administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”).


 


(hh)
  U.S. Real Property Holding Corporation.  The Company is not and has never been a U.S. real property holding
corporation within the meaning of Section 897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify
upon Purchaser’s request.


 






    22


     

    

 


(ii)
  Bank Holding Company Act.  Neither the Company nor any of its Subsidiaries or Affiliates is subject to
the Bank Holding Company Act of 1956, as amended (the “BHCA”) and to regulation by the Board of Governors of the Federal
Reserve System (the “Federal Reserve”). Neither the Company nor any of its Subsidiaries or Affiliates owns or controls,
directly or indirectly, five percent (5%) or more of the outstanding shares of any class of voting securities or twenty-five percent
(25%) or more of the total equity of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve.
Neither the Company nor any of its Subsidiaries or Affiliates exercises a controlling influence over the management or policies
of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve.


 


(jj)
Solvency. Based on the consolidated financial condition of the Company as of the applicable Closing Date, after giving
effect to the receipt by the Company of the proceeds from the sale of the Securities hereunder: (i) the fair saleable value
of the Company’s assets exceeds the amount that will be required to be paid on or in respect of the Company’s existing
debts and other liabilities (including known contingent liabilities) as they mature, (ii) the Company’s assets do not
constitute unreasonably small capital to carry on its business as now conducted and as proposed to be conducted including its
capital needs taking into account the particular capital requirements of the business conducted by the Company, consolidated and
projected capital requirements and capital availability thereof, and (iii) the current cash flow of the Company, together
with the proceeds the Company would receive, were it to liquidate all of its assets, after taking into account all anticipated
uses of the cash, would be sufficient to pay all amounts on or in respect of its liabilities when such amounts are required to
be paid. The Company does not intend to incur debts beyond its ability to pay such debts as they mature (taking into account the
timing and amounts of cash to be payable on or in respect of its debt). The Company has no knowledge of any facts or circumstances
which lead it to believe that it will file for reorganization or liquidation under the bankruptcy or reorganization laws of any
jurisdiction within one year from the applicable Closing Date. Schedule 3.1(jj) sets forth as of the date hereof all outstanding
secured and unsecured Indebtedness of the Company or any Subsidiary, or for which the Company or any Subsidiary has commitments.
For the purposes of this Agreement, “Indebtedness” means (x) any liabilities for borrowed money or amounts owed
in excess of $50,000 (other than trade accounts payable incurred in the ordinary course of business), (y) all guaranties,
endorsements and other contingent obligations in respect of indebtedness of others, whether or not the same are or should be reflected
in the Company’s consolidated balance sheet (or the notes thereto), except guaranties by endorsement of negotiable instruments
for deposit or collection or similar transactions in the ordinary course of business; and (z) the present value of any lease
payments in excess of $50,000 due under leases required to be capitalized in accordance with GAAP. Neither the Company nor any
Subsidiary is in default with respect to any Indebtedness.


 






    23


     

    

 


(kk)
Tax Status. Except for matters that would not, individually or in the aggregate, have or reasonably be expected to result
in a Material Adverse Effect, the Company (i) has made or filed all United States federal, state and local income and all
foreign income and franchise tax returns, reports and declarations required by any jurisdiction to which it is subject, (ii) has
paid all taxes and other governmental assessments and charges that are material in amount, shown or determined to be due on such
returns, reports and declarations and (iii) has set aside on its books provision reasonably adequate for the payment of all
material taxes for periods subsequent to the periods to which such returns, reports or declarations apply. Except as set forth
on Schedule 3.1(kk), there are no unpaid taxes in any material amount claimed to be due by the taxing authority of any jurisdiction,
and the officers of the Company know of no basis for any such claim.


 


(ll)
Seniority. As of each Closing Date, except as set forth on Schedule 3.1(ll), no Indebtedness or other claim against the
Company is senior to the Notes in right of payment, whether with respect to interest or upon liquidation or dissolution, or otherwise,
other than indebtedness secured by purchase money security interests (which is senior only as to underlying assets covered thereby)
and capital lease obligations (which is senior only as to the property covered thereby).


 


(mm)Acknowledgment
Regarding Purchaser’s Trading Activity. Anything in this Agreement or elsewhere herein to the contrary notwithstanding
(except for Sections 3.2(f) and 4.12 hereof), it is understood and acknowledged by the Company that: (i) the Purchaser has not
been asked by the Company to agree, nor has the Purchaser agreed, to desist from purchasing or selling, long and/or short, securities
of the Company, or “derivative” securities based on securities issued by the Company or to hold the Securities for
any specified term; (ii) past or future open market or other transactions by the Purchaser, specifically including, without limitation,
Short Sales or “derivative” transactions, before or after the closing of this or future private placement transactions,
may negatively impact the market price of the Company’s publicly-traded securities; (iii) the Purchaser, and counter-parties
in “derivative” transactions to which the Purchaser is a party, directly or indirectly, may presently have a “short”
position in the Common Stock; and (iv) the Purchaser shall not be deemed to have any affiliation with or control over any arm’s
length counter-party in any “derivative” transaction. The Company further understands and acknowledges that
(x) the Purchaser may engage in hedging activities at various times during the period that the Securities are outstanding, including,
without limitation, during the periods that the value of the Conversion Shares or the Underlying Shares deliverable with respect
to Securities are being determined, and (y) such hedging activities (if any) could reduce the value of the existing stockholders'
equity interests in the Company at and after the time that the hedging activities are being conducted.  The Company acknowledges
that such aforementioned hedging activities do not constitute a breach of any of the Transaction Documents.


 


(nn)
Money Laundering. The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance
with applicable financial record-keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of
1970, as amended, applicable money laundering statutes and applicable rules and regulations thereunder (collectively, the “Money
Laundering Laws”), and no action, suit or proceeding by or before any court or governmental agency, authority or body or
any arbitrator involving the Company or any Subsidiary with respect to the Money Laundering Laws is pending or, to the knowledge
of the Company or any Subsidiary, threatened.


 






    24


     

    

 


3.2
  Representations and Warranties of the Purchaser. The Purchaser hereby represents and warrants as of the date hereof and
as of the Closing Date to the Company and NACD as follows (unless as of a specific date therein):


 


(a)
  Organization; Authority.  The Purchaser is either an individual or an entity duly incorporated or formed,
validly existing and in good standing under the laws of the jurisdiction of its incorporation or formation with full right, corporate,
partnership, limited liability company or similar power and authority to enter into and to consummate the transactions contemplated
by the Transaction Documents and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of
the Transaction Documents and performance by the Purchaser of the transactions contemplated by the Transaction Documents have
been duly authorized by all necessary corporate, partnership, limited liability company or similar action, as applicable, on the
part of the Purchaser.  Each Transaction Document to which it is a party has been duly executed by the Purchaser, and
when delivered by the Purchaser in accordance with the terms hereof, will constitute the valid and legally binding obligation
of the Purchaser, enforceable against it in accordance with its terms, except: (i) as limited by general equitable principles
and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement
of creditors’ rights generally; (ii) as limited by laws relating to the availability of specific performance, injunctive
relief or other equitable remedies; and (iii) insofar as indemnification and contribution provisions may be limited by applicable
law.


 


(b)
  Own Account.  The Purchaser understands that the Securities are “restricted securities” and
have not been registered under the Securities Act or any applicable state securities law and is acquiring the Securities as principal
for its own account and not with a view to or for distributing or reselling such Securities or any part thereof in violation of
the Securities Act or any applicable state securities law, has no present intention of distributing any of such Securities in
violation of the Securities Act or any applicable state securities law and has no direct or indirect arrangement or understandings
with any other persons to distribute or regarding the distribution of such Securities in violation of the Securities Act or any
applicable state securities law (this representation and warranty not limiting the Purchaser’s right to sell the Securities
in compliance with applicable federal and state securities laws).  The Purchaser is acquiring the Securities hereunder
in the ordinary course of its business.


 


(c)
  Purchaser Status.  At the time the Purchaser was offered the applicable Securities, it was, and as of
the date hereof it is, and on each date on which it converts any Preferred Shares, or as applicable, the Notes, it will be an
“accredited investor” as defined in Rule 501 under the Securities Act.


 






    25


     

    

 


(d)
  Experience of The Purchaser.  The Purchaser, either alone or together with its representatives, has such
knowledge, sophistication and experience in business and financial matters so as to be capable of evaluating the merits and risks
of the prospective investment in the Securities, and has so evaluated the merits and risks of such investment.  The
Purchaser is able to bear the economic risk of an investment in the Securities and, at the present time, is able to afford a complete
loss of such investment.


 


(e)
  General Solicitation.  The Purchaser is not purchasing the Securities as a result of any advertisement,
article, notice or other communication regarding the Securities published in any newspaper, magazine or similar media or broadcast
over television or radio or presented at any seminar or any other general solicitation or general advertisement.


 


(f)
  Certain Transactions and Confidentiality.  Other than consummating the transactions contemplated hereunder,
the Purchaser has not directly or indirectly, nor has any Person acting on behalf of or pursuant to any understanding with the
Purchaser, executed any purchases or sales, including Short Sales, of the securities of the Company during the period commencing
as of the time that the Purchaser first received a term sheet (written or oral) from the Company or any other Person representing
the Company setting forth the material terms of the transactions contemplated hereunder and ending immediately prior to the execution
hereof.  Notwithstanding the foregoing, in the case of a Purchaser that is a multi-managed investment vehicle whereby
separate portfolio managers manage separate portions of the Purchaser’s assets and the portfolio managers have no direct
knowledge of the investment decisions made by the portfolio managers managing other portions of the Purchaser’s assets,
the representation set forth above shall only apply with respect to the portion of assets managed by the portfolio manager that
made the investment decision to purchase the Securities covered by this Agreement.  Other than to other Persons party
to this Agreement, the Purchaser has maintained the confidentiality of all disclosures made to it in connection with this transaction
(including the existence and terms of this transaction). Notwithstanding the foregoing, for avoidance of doubt, nothing contained
herein shall constitute a representation or warranty, or preclude any actions, with respect to the identification of the availability
of, or securing of, available shares to borrow in order to effect Short Sales or similar transactions in the future.


 


(g)
Acknowledgement of Risk. Purchaser acknowledges that an investment in the Company and NACD involves a very high degree
of risk and that such investment should not be undertaken if the Purchaser cannot afford to lose the Purchaser’s entire
investment. The Purchaser acknowledges and confirms that the Purchaser can bear the economic risk of the purchase of the Securities,
including a total loss of the Purchaser’s investment.


 






    26


     

    

 


(h)
No Advice by the Company. Purchaser acknowledges that it has carefully considered and has discussed with its legal, tax,
accounting and financial advisors the suitability of this investment and the transactions contemplated by this Agreement for the
Purchaser’s particular federal, state, local and foreign tax and financial situation and has independently determined that
this investment and the transactions contemplated by this Agreement are a suitable investment for Purchaser. Purchaser has relied
solely on such advisors and not on any statements or representations of the Company or any of its agents. Purchaser understands
that Purchaser (and not the Company or NACD or any officer, director or stockholder of the Company) shall be responsible for Purchaser’s
own tax liability that may arise as a result of this investment or the transactions contemplated by this Agreement.


 


The
Company acknowledges and agrees that the representations contained in Section 3.2 shall not modify, amend or affect the Purchaser’s
right to rely on the Company’s representations and warranties contained in this Agreement or any representations and warranties
contained in any other Transaction Document or any other document or instrument executed and/or delivered in connection with this
Agreement or the consummation of the transaction contemplated hereby. 


 



ARTICLE
IV. 


OTHER
AGREEMENTS OF THE PARTIES 


 


4.1
  Transfer Restrictions.


 


(a)
  The Securities may only be disposed of in compliance with state and federal securities laws.  In connection with
any transfer of Securities other than pursuant to an effective registration statement or Rule 144, to the Company or to an Affiliate
of a Purchaser or in connection with a pledge as contemplated in Section 4.1(b), the Company may require the transferor thereof
to provide to the Company an opinion of counsel selected by the transferor and reasonably acceptable to the Company, the form
and substance of which opinion shall be reasonably satisfactory to the Company, to the effect that such transfer does not require
registration of such transferred Securities under the Securities Act.  As a condition of transfer, any such transferee
shall agree in writing to be bound by the terms of this Agreement and shall have the rights and obligations of a Purchaser under
this Agreement.


 


(b)
  The Purchaser agrees to the imprinting, so long as is required by this Section 4.1, of a legend on any of the Securities
in the following form:


 


[NEITHER]
THIS SECURITY [NOR THE SECURITIES INTO WHICH THIS SECURITY IS [CONVERTIBLE] HAS [NOT] BEEN REGISTERED WITH THE SECURITIES AND
EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES
ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN
EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT
SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED
BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY.  THIS
SECURITY [AND THE SECURITIES ISSUABLE UPON [CONVERSION] OF THIS SECURITY] MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN
ACCOUNT WITH A REGISTERED BROKER-DEALER OR OTHER LOAN WITH A FINANCIAL INSTITUTION THAT IS AN “ACCREDITED INVESTOR”
AS DEFINED IN RULE 501(A) UNDER THE SECURITIES ACT OR OTHER LOAN SECURED BY SUCH SECURITIES. 


 






    27


     

    

 


The
Company acknowledges and agrees that the Purchaser may from time to time pledge pursuant to a bona fide margin agreement with
a registered broker-dealer or grant a security interest in some or all of the Securities to a financial institution that is an
“accredited investor” as defined in Rule 501(a) under the Securities Act and who agrees to be bound by the provisions
of this Agreement and, if required under the terms of such arrangement, the Purchaser may transfer pledged or secured Securities
to the pledgees or secured parties.  Such a pledge or transfer would not be subject to approval of the Company and no
legal opinion of legal counsel of the pledgee, secured party or pledgor shall be required in connection therewith.  Further,
no notice shall be required of such pledge.  At the appropriate Purchaser’s expense, the Company will execute
and deliver such reasonable documentation as a pledgee or secured party of Securities may reasonably request in connection with
a pledge or transfer of the Securities. 


 


(c)
  Certificates evidencing the NACD Common Shares, the Conversion Shares, or the Underlying Shares. 


 


(i)
Certificates evidencing the NACD Common Shares shall at all times contain the legend set forth in Section 4.1(b) hereof and shall
be restricted securities. 


 


(ii)
Certificates evidencing the Conversion Shares shall not contain any legend (including the legend set forth in Section 4.1(b) hereof):
(a) while a registration statement covering the resale of such security is effective under the Securities Act; (b) following any
sale of such Conversion Shares pursuant to Rule 144; (c) if such Conversion Shares are eligible for sale under Rule 144; or (d)
if such legend is not required under applicable requirements of the Securities Act (including judicial interpretations and pronouncements
issued by the staff of the Commission). The Company shall, upon request of a Purchaser and at the Company’s expense, cause
Company Counsel (or another counsel reasonably acceptable to the Purchaser) to issue a legal opinion to the Transfer Agent promptly
after any of the events described in (a)-(d) in the preceding sentence if required by the Transfer Agent to effect the removal
of the legend hereunder (with a copy to the Purchaser and its broker). If all or any portion of a Preferred Share is converted
at a time when there is an effective registration statement to cover the resale of the Conversion Shares, or if such Conversion
Shares are actually sold under Rule 144 or if such legend is not otherwise required under applicable requirements of the Securities
Act (including judicial interpretations and pronouncements issued by the staff of the Commission) then such Conversion Shares
shall be issued free of all legends.  The Company agrees that following the Effective Date or at such time as such legend
is no longer required under this Section 4.1(c)(ii), it will, no later than two (2) Trading Days following the delivery by the
Purchaser to the Company or the Transfer Agent of a certificate representing Conversion Shares, issued with a restrictive legend
(such third Trading Day, the “Preferred Share Legend Removal Date”), instruct the Transfer Agent to deliver or cause
to be delivered to the Purchaser a certificate representing such shares that is free from all restrictive and other legends.  The
Company may not make any notation on its records or give instructions to the Transfer Agent that enlarge the restrictions on transfer
set forth in this Section 4.  Certificates for Conversion Shares subject to legend removal hereunder shall be transmitted
by the Transfer Agent to the Purchaser by crediting the account of the Purchaser’s prime broker with the Depository Trust
Company System as directed by the Purchaser. Notwithstanding anything to the foregoing, the Purchaser acknowledge that the Company
was at one point a “shell company” as defined under Rule 144 and therefore in order for sales of Company securities
to be effected under Rule 144 and legends from such securities removed, the Company must be current in its reporting obligations
under the Exchange Act. 


 






    28


     

    

 


(iii)            
Certificates evidencing the Underlying Shares, shall not contain any legend (including the legend set forth in Section
4.1(b) hereof): (a) while a registration statement covering the resale of such security is effective under the Securities Act;
(b) following any sale of such Underlying Shares pursuant to Rule 144; (c) if such Underlying Shares are eligible for sale under
Rule 144; or (d) if such legend is not required under applicable requirements of the Securities Act (including judicial interpretations
and pronouncements issued by the staff of the Commission). The Company shall, upon request of a Purchaser and at the Purchaser’s
expense, cause its counsel to issue a legal opinion to the Transfer Agent promptly after any of the events described in (a)-(d)
in the preceding sentence if required by the Transfer Agent to effect the removal of the legend hereunder (with a copy to the
applicable Purchaser and its broker). If all or any portion of a Note is converted at a time when there is an effective registration
statement to cover the resale of the Underlying Shares, or if such Underlying Shares are actually sold under Rule 144 or if such
legend is not otherwise required under applicable requirements of the Securities Act (including judicial interpretations and pronouncements
issued by the staff of the Commission) then such Underlying Shares shall be issued free of all legends.  The Company
agrees that following the Effective Date or at such time as such legend is no longer required under this Section 4.1(c)(iii),
it will, no later than two (2) Trading Days following the delivery by a Purchaser to the Company or the Transfer Agent of a certificate
representing Underlying Shares, issued with a restrictive legend (such third Trading Day, the “Note Legend Removal Date”),
instruct the Transfer Agent to deliver or cause to be delivered to the Purchaser a certificate representing such shares that is
free from all restrictive and other legends.  The Company may not make any notation on its records or give instructions
to the Transfer Agent that enlarge the restrictions on transfer set forth in this Section 4.  Certificates for Underlying
Shares subject to legend removal hereunder shall be transmitted by the Transfer Agent to the Purchaser by crediting the account
of the Purchaser’s prime broker with the Depository Trust Company System as directed by the Purchaser. Notwithstanding anything
to the foregoing, the Purchaser acknowledge that the Company was at one point a “shell company” as defined under Rule
144 and therefore in order for sales of Company securities to be effected under Rule 144 and legends from such securities removed,
the Company must be current in its reporting obligations under the Exchange Act..


 


(d)
In addition to the Purchaser’s other available remedies, the Company shall pay to a Purchaser, in cash, as partial liquidated
damages and not as a penalty, $500 per Trading Day for each Trading Day after the Note Legend Removal Date or the Preferred Share
Legend Removal Date until such certificate is delivered without a legend. Nothing herein shall limit the Purchaser’s right
to pursue actual damages for the Company’s failure to deliver certificates representing any Securities as required by the
Transaction Documents, and the Purchaser shall have the right to pursue all remedies available to it at law or in equity including,
without limitation, a decree of specific performance and/or injunctive relief. 


 






    29


     

    

  


4.2
  Acknowledgment of Dilution.  The Company acknowledges that the issuance of the Securities may result in
dilution of the outstanding shares of Common Stock, which dilution may be substantial under certain market conditions.  The
Company further acknowledges that its obligations under the Transaction Documents, including, without limitation, its obligation
to issue the Conversion Shares or the Underlying Shares pursuant to the Transaction Documents, are unconditional and absolute
and not subject to any right of set off, counterclaim, delay or reduction, regardless of the effect of any such dilution or any
claim the Company may have against the Purchaser and regardless of the dilutive effect that such issuance may have on the ownership
of the other stockholders of the Company.


 


4.3
  Furnishing of Information; Public Information.


 


(a)
  The Company covenants to maintain the registration of the Common Stock under Section 12(b) or 12(g) of the Exchange Act
and to timely file (or obtain extensions in respect thereof and file within the applicable grace period) all reports required
to be filed by the Company after the date hereof pursuant to the Exchange Act even if the Company is not then subject to the reporting
requirements of the Exchange Act. Notwithstanding anything to the contrary contained in this Section 4.3(a), the Company shall
be permitted to file with the Commission on or before January 15, 2017, (i) an amendment to that certain Current Report on Form
8-K filed with the Commission on August 18, 2016, and (ii) a Quarterly Report on Form 10-Q for the period ended September 30,
2016.


 


(b)    At
any time during the period commencing from the six (6) month anniversary of the date hereof and ending at such time that all of
the Securities (other than the NACD Common Shares, which shall be excluded from the definition of Securities, solely for purposes
of this Section 4.3) may be sold without the requirement for the Company to be in compliance with Rule 144(c)(1) and otherwise
without restriction or limitation pursuant to Rule 144, if the Company shall fail for any reason to satisfy the current public
information requirement under Rule 144(c) (a “Public Information Failure”) then, in addition to the Purchaser’s
other available remedies, the Company shall pay to a Purchaser, in cash, as partial liquidated damages and not as a penalty, by
reason of any such delay in or reduction of its ability to sell the Securities, an amount in cash equal to two percent (2.0%)
of the aggregate Subscription Amount of the Purchaser’s Securities on the day of a Public Information Failure and on every
thirtieth (30th) day (pro-rated for periods totaling less than thirty days) thereafter until the earlier of (a) the
date such Public Information Failure is cured and (b) such time that such public information is no longer required  for the
Purchaser to transfer the Conversion Shares or the Underlying Shares pursuant to Rule 144.  The payments to which a Purchaser
shall be entitled pursuant to this Section 4.3(b) are referred to herein as “Public Information Failure Payments.” 
Public Information Failure Payments shall be paid on the earlier of (i) the last day of the calendar month during which such
Public Information Failure Payments are incurred and (ii) the third (3rd) Business Day after the event or failure
giving rise to the Public Information Failure Payments is cured.  In the event the Company fails to make Public Information
Failure Payments in a timely manner, such Public Information Failure Payments shall bear interest at the rate of 1.5%
per month (prorated for partial months) until paid in full. Nothing herein shall limit the Purchaser’s right to pursue actual
damages for the Public Information Failure, and the Purchaser shall have the right to pursue all remedies available to it at law
or in equity including, without limitation, a decree of specific performance and/or injunctive relief. 


 






    30


     

    

 


4.4
  Integration.  The Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate
in respect of any security (as defined in Section 2 of the Securities Act) that would be integrated with the offer or sale of
the Securities in a manner that would require the registration under the Securities Act of the sale of the Securities or that
would be integrated with the offer or sale of the Securities for purposes of the rules and regulations of any Trading Market such
that it would require shareholder approval prior to the closing of such other transaction unless shareholder approval is obtained
before the closing of such subsequent transaction. 


 


4.5
  Conversion Procedures.  The form of the Conversion Notice and Notice of Conversion included in the Certificate
of Designations and Notes, respectively, sets forth the totality of the procedures required of the Purchaser in order to convert
the Preferred Shares or the Notes, respectively.  Without limiting the preceding sentences, no ink-original Conversion
Notice, or as applicable, Notice of Conversion, shall be required, nor shall any medallion guarantee (or other type of guarantee
or notarization) of any Conversion Notice, or as applicable, Notice of Conversion, form be required in order to convert the Preferred
Shares or the Note, respectively.  No additional legal opinion, other information or instructions shall be required
of the Purchaser to convert its Preferred Shares, or as applicable, its Notes.  The Company shall honor conversions
of the Preferred Shares, or as applicable, the Notes, and shall deliver Conversion Shares or Underlying Shares, respectively,
in accordance with the terms, conditions and time periods set forth in the Transaction Documents.


 


4.6
  Shareholder Rights Plan.  No claim will be made or enforced by the Company or, with the consent of the
Company, any other Person, that the Purchaser is an “Acquiring Person” under any control share acquisition, business
combination, poison pill (including any distribution under a rights agreement) or similar anti-takeover plan or arrangement in
effect or hereafter adopted by the Company, or that the Purchaser could be deemed to trigger the provisions of any such plan or
arrangement, by virtue of receiving Securities under the Transaction Documents or under any other agreement between the Company
and the Purchaser.


 






    31


     

    

 


4.7
  Non-Public Information.  Following the filing by the Company with the Commission of the Company’s
pending audit of Swiss Heights Engineering S.A., the Company covenants and agrees that neither it, nor any other Person acting
on its behalf, will provide the Purchaser or its agents or counsel with any information that the Company believes constitutes
material non-public information, unless prior thereto the Purchaser shall have entered into a written agreement with the Company
regarding the confidentiality and use of such information.  The Company understands and confirms that the Purchaser
shall be relying on the foregoing covenant in effecting transactions in securities of the Company.


 


4.8
  Use of Proceeds.  The Company may use the net proceeds hereunder at its sole discretion.


 


4.9
  Indemnification of Purchaser.   Subject to the provisions of this Section 4.10, the Company will
indemnify and hold the Purchaser and its directors, officers, shareholders, members, partners, employees and agents (and any other
Persons with a functionally equivalent role of a Person holding such titles notwithstanding a lack of such title or any other
title), each Person who controls the Purchaser (within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange
Act), and the directors, officers, shareholders, agents, members, partners or employees (and any other Persons with a functionally
equivalent role of a Person holding such titles notwithstanding a lack of such title or any other title) of such controlling persons
(each, a “Purchaser Party”) harmless from any and all losses, liabilities, obligations, claims, contingencies, damages,
costs and expenses, including all judgments, amounts paid in settlements, court costs and reasonable attorneys’ fees and
costs of investigation that any the Purchaser Party may suffer or incur as a result of or relating to (a) any breach of any of
the representations, warranties, covenants or agreements made by the Company in this Agreement or in the other Transaction Documents
or (b) any action instituted against the Purchaser Parties in any capacity, or any of them or their respective Affiliates, by
any stockholder of the Company who is not an Affiliate of the Purchaser Party, with respect to any of the transactions contemplated
by the Transaction Documents (unless such action is based upon a breach of the Purchaser Party’s representations, warranties
or covenants under the Transaction Documents or any agreements or understandings the Purchaser Party may have with any such stockholder
or any violations by such  Purchaser Party of state or federal securities laws or any conduct by the Purchaser Party
which constitutes fraud, gross negligence, willful misconduct or malfeasance).  If any action shall be brought against
any Purchaser Party in respect of which indemnity may be sought pursuant to this Agreement, the Purchaser Party shall promptly
notify the Company in writing, and the Company shall have the right to assume the defense thereof with counsel of its own choosing
reasonably acceptable to the Purchaser Party.  Any Purchaser Party shall have the right to employ separate counsel in
any such action and participate in the defense thereof, but the fees and expenses of such counsel shall be at the expense of the
Purchaser Party except to the extent that (i) the employment thereof has been specifically authorized by the Company in writing,
(ii) the Company has failed after a reasonable period of time to assume such defense and to employ counsel or (iii) in such action
there is, in the reasonable opinion of counsel, a material conflict on any material issue between the position of the Company
and the position of the Purchaser Party, in which case the Company shall be responsible for the reasonable fees and expenses of
no more than one such separate counsel.  The Company will not be liable to any Purchaser Party under this Agreement
(x) for any settlement by a Purchaser Party effected without the Company’s prior written consent, which shall not be unreasonably
withheld or delayed; or (y) to the extent, but only to the extent that a loss, claim, damage or liability is attributable to any
Purchaser Party’s breach of any of the representations, warranties, covenants or agreements made by the Purchaser Party
in this Agreement or in the other Transaction Documents.  The indemnification required by this Section 4.10 shall be
made by periodic payments of the amount thereof during the course of the investigation or defense, as and when bills are received
or are incurred.  The indemnification contained herein shall be in addition to any cause of action or similar right
of any Purchaser Party against the Company or others and any liabilities the Company may be subject to pursuant to law.


 






    32


     

    

 


4.10  
Reservation and Listing of Securities.


 


(a)
  The Company shall maintain a reserve from its duly authorized shares of Common Stock for issuance pursuant to the Transaction
Documents in such amount as may then be required to fulfill its obligations in full under the Transaction Documents.


 


(b)
  If, on any date, the number of authorized but unissued (and otherwise unreserved) shares of Common Stock is less than the
agreed upon Required Minimum multiplied by a certain percentage (the “Reserve”) on such date, then the Board of Directors
shall use commercially reasonable efforts to amend the Company’s certificate or articles of incorporation to increase the
number of authorized but unissued shares of Common Stock to at least 300% of the Required Minimum at such time, as soon as possible
and in any event not later than the 75th day after such date. For the avoidance of doubt, the Company and the Purchaser
agree that the Reserve shall be mutually agreed upon at a reasonable time after the First Closing, but in no event, later than
thirty (30) days after the filing of the Definitive Information Statement on Schedule 14C with the Commission, as set forth in
Section 4.16(b) herein.


 


(c)
  The Company shall, if applicable: (i) in the time and manner required by the principal Trading Market, prepare and file
with such Trading Market an additional shares listing application covering a number of shares of Common Stock at least equal to
the Required Minimum on the date of such application; (ii) take all steps necessary to cause such shares of Common Stock to be
approved for listing or quotation on such Trading Market as soon as possible thereafter; (iii) provide to the Purchaser evidence
of such listing or quotation; and (iv) maintain the listing or quotation of such Common Stock on any date at least equal to the
Required Minimum on such date on such Trading Market or another Trading Market.


 


4.11
  Reserved.


 


4.12
  Certain Transactions and Confidentiality. The Purchaser, covenants that neither it, nor any Affiliate acting on
its behalf or pursuant to any understanding with it will execute any Short Sales, of any of the Company’s securities during
the period commencing with the execution of this Agreement and ending on  the date that the Preferred Shares, or as
applicable, the Notes are no longer outstanding (provided that this provision shall not prohibit any sales made where a corresponding
Notice of Conversion is tendered to the Company and the shares received upon such conversion or exercise are used to close out
such sale) (a “Prohibited Short Sale”). 


 






    33


     

    

 


4.13
Right of First Refusal.


(a)
From the date hereof until the date that is the six (6) month anniversary of the last Closing, upon any issuance by the Company
of Common Stock, Common Stock Equivalents or debt for cash consideration, Indebtedness or a combination of units hereof (a “Subsequent
Financing”), the Purchaser shall have the right to participate in up to an amount of the Subsequent Financing equal to 100%
of the Subsequent Financing (the “Participation Maximum”) on the same terms, conditions and price provided for in
the Subsequent Financing.


 


(b)
 At least five (5) Trading Days prior to the closing of the Subsequent Financing, the Company shall deliver to the Purchaser
a written notice of its intention to effect a Subsequent Financing (“Pre-Notice”), which Pre-Notice shall ask the
Purchaser if it wants to review the details of such financing (such additional notice, a “Subsequent Financing Notice”).
Upon the request of a Purchaser, and only upon a request by the Purchaser, for a Subsequent Financing Notice, the Company shall
promptly, but no later than one (1) Trading Day after such request, deliver a Subsequent Financing Notice to the Purchaser. The
Subsequent Financing Notice shall describe in reasonable detail the proposed terms of such Subsequent Financing, the amount of
proceeds intended to be raised thereunder and the Person or Persons through or with whom such Subsequent Financing is proposed
to be effected and shall include a term sheet or similar document relating thereto as an attachment.


 


(c)
 If the Purchaser desires to participate in such Subsequent Financing, the Purchaser must provide written notice to the Company
that the Purchaser is willing to participate in the Subsequent Financing, the amount of the Purchaser’s participation, and
representing and warranting that the Purchaser has such funds ready, willing, and available for investment on the terms set forth
in the Subsequent Financing Notice.


 


(d)
  If notifications by the Purchaser of its willingness to participate in the Subsequent Financing (or to cause their designees
to participate) is, in the aggregate, less than the total amount of the Subsequent Financing, then the Company may effect the
remaining portion of such Subsequent Financing on the terms and with any of the Persons set forth in the Subsequent Financing
Notice.


 


(e)
  The Company must provide the Purchaser with a second Subsequent Financing Notice, and the Purchaser will again have the
right of participation set forth above in this Section 4.13, if the Subsequent Financing subject to the initial Subsequent Financing
Notice is not consummated for any reason on the terms set forth in such Subsequent Financing Notice within thirty (30) Trading
Days after the date of the initial Subsequent Financing Notice.


 


(f)
  The Company and the Purchaser agree that if the Purchaser elects to participate
in the Subsequent Financing, the transaction documents related to the Subsequent Financing shall not include any term or provision
whereby the Purchaser shall be required to agree to any restrictions on trading as to any of the Securities purchased hereunder
or be required to consent to any amendment to or termination of, or grant any waiver, release or the like under or in connection
with, this Agreement, without the prior written consent of the Purchaser.


 






    34


     

    

 


(g)
  Notwithstanding anything to the contrary in this Section 4.13 and unless otherwise
agreed to by the Purchaser, the Company shall either confirm in writing to the Purchaser that the transaction with respect to
the Subsequent Financing has been abandoned or shall publicly disclose its intention to issue the securities in the Subsequent
Financing, in either case in such a manner such that the Purchaser will not be in possession of any material, non-public information,
by the tenth (10th) Trading Day following delivery of the Subsequent Financing Notice. If by such tenth (10th)
Trading Day, no public disclosure regarding a transaction with respect to the Subsequent Financing has been made, and no notice
regarding the abandonment of such transaction has been received by the Purchaser, such transaction shall be deemed to have been
abandoned and the Purchaser shall not be deemed to be in possession of any material, non-public information with respect to the
Company or any of its Subsidiaries. 


 


(h)
  Notwithstanding the foregoing, this Section 4.13 shall not apply in respect of an Exempt Issuance.


 


4.14
Securities Laws Disclosure; Publicity. The Company shall by the fourth (4th) Trading Day immediately following
the date hereof file with the Commission a Current Report on Form 8-K, including the Transaction Documents as exhibits thereto,
with the Commission within the time required by the Exchange Act. The Company represents to the Purchaser that following the filing
by the Company with the Commission of the Company’s pending audit of Swiss Heights Engineering S.A., the Company shall have
publicly disclosed all material, non-public information delivered to the Purchaser by the Company or any of its Subsidiaries,
or any of their respective officers, directors, employees or agents in connection with the transactions contemplated by the Transaction
Documents. The Company and the Purchaser shall consult with each other in issuing any other press releases with respect to the
transactions contemplated hereby, and neither the Company nor the Purchaser shall issue any such press release nor otherwise make
any such public statement without the prior consent of the Company, with respect to any press release of the Purchaser, or without
the prior consent of the Purchaser, with respect to any press release of the Company, which consent shall not unreasonably be
withheld or delayed, except if such disclosure is required by law, in which case the disclosing party shall promptly provide the
other party with prior notice of such public statement or communication. Notwithstanding the foregoing, the Company shall not
publicly disclose the name of the Purchaser, or include the name of the Purchaser in any filing with the Commission or any regulatory
agency or Trading Market, without the prior written consent of the Purchaser, except: (a) as required by federal securities law
in connection with any registration statement contemplated by this Agreement and (b) to the extent such disclosure is required
by law or Trading Market regulations, in which case the Company shall provide the Purchaser with prior notice of such disclosure
permitted under this clause (b).


 






    35


     

    

 


4.15
Form D; Blue Sky Filings. The Company agrees to timely file a Form D with respect to the Securities as required under Regulation
D and to provide a copy thereof, promptly upon request of the Purchaser. The Company shall also take such action as the Company
shall reasonably determine is necessary in order to obtain an exemption for, or to qualify the Securities for, sale to the Purchaser
at the applicable Closing under applicable securities or “Blue Sky” laws of the states of the United States, and shall
provide evidence of such actions promptly upon request of the Purchaser.


 


4.16
Post-Closing Covenants.


 


		(a)	The
                                         Company shall use its commercially reasonable best efforts to deliver to the Purchaser
                                         within thirty (30) days from the date hereof a Deposit Account Control Agreement, duly
                                         executed by the Company and the bank or financial institution, in a form reasonably satisfactory
                                         to the Purchaser.



 


		(b)	The
                                         Company shall use its commercially reasonable best efforts to file a Definitive Information
                                         Statement on Schedule 14C with the Commission within ten (10) days from November 3, 2016,
                                         with respect to (i) the Company's stockholders’ approval of the creation and authorization
                                         of the Series A Preferred Stock, and (ii) the Company's stockholders' approval of a reverse
                                         stock split of the Company's common stock in a ratio ranging from 50-to-1 to 200-to-1.
                                         In the event that the Commission provides comments to the related Preliminary Information
                                         Statement on Schedule 14C, the Company shall use its commercially reasonable best efforts
                                         to file the Definitive Information Statement on Schedule 14C on or before December 30,
                                         2016.



 


		(c)	The
                                         Company shall use its commercially reasonable best efforts to file the Certificate of
                                         Designations with the Secretary of State of the State of Nevada on the twenty-first (21st)
                                         days following the date of filing of the Definitive Information Statement referred to
                                         in Section 4.16(b).



 


		(d)	The
                                         Company shall use its commercially reasonable best efforts to issue to the Purchaser
                                         the shares of Series A Preferred Stock within two (2) days from the date of filing of
                                         the Certificate of Designations with the Secretary of State of the State of Nevada.



 


		(e)	In
                                         the event that the Company is required to issue Notes to the Purchase in accordance with
                                         Section 2.5 herein, the Company shall provide the Purchaser with all of the fully executed
                                         transaction documents related to the Notes.



 


		(f)	Upon
                                         the date hereof, the Company shall cause the Purchaser to have complete access to on-line
                                         banking in connection with the “springing account” at BBVA Houston (the “BBVA
                                         Houston Account”) and shall be entitled to monitor the BBVA Houston Account at
                                         all times. In the event that the Company or any of its Subsidiaries breach any of the
                                         Transaction Documents, the Purchaser shall have the right to “call” the amounts
                                         from the BBVA Houston Account up to the amount required to be paid to or owed to the
                                         Purchaser, and the Company shall use commercially reasonably best efforts to effect same.
                                         The Company and its Subsidiaries agree that certain receivables and payment orders must
                                         be deposited into the BBVA Houston Account as of the date hereof, and such receivables
                                         and payment orders are listed on Schedule 4.16(f) hereto (the “Receive bales”).



 






    36


     

    

 


		(g)	On
                                         the tenth (10th) of each month, the Purchaser shall receive a detailed report
                                         of the Receivables. In the event that the aggregate amount of the Receivables is less
                                         than USD $3,000,000, the Company and the Subsidiaries shall fund the BBVA Houston Account
                                         with new receivables and/or payments order in order to meet the foregoing USD $3,000,000
                                         minimum.



 


		(h)	The
                                         Company shall deliver to the Purchaser those certain bank statements as set forth on
                                         Schedule 4.16(h) hereto, within two (2) Business days of the Purchaser’ request
                                         (so long as the Security Documents remain in effect in accordance with their terms).



 


		(i)	The
                                         Registration Statement shall be filed with the Commission within seven (7) business days
                                         of January 15, 2017. The Company shall cause the Registration Statement to be declared
                                         effective by the Commission by no later than the following: (i) 90 days from the initial
                                         filing of the Registration Statement, in the event that the Company receives twenty-five
                                         (25) or fewer comments from the Commission with respect to the initial filing of the
                                         Registration Statement; or (ii) 120 days from the initial filing of the Registration
                                         Statement, in the event that the Company receives more than twenty-five (25) comments
                                         from the Commission with respect to the initial filing of the Registration Statement.



 


		(j)	In
                                         the event that any deliverables that are required to be delivered on the First Closing
                                         (as described in Section 2.3 herein) are not delivered on the First Closing, they shall
                                         be delivered on or before November 11, 2016. In the event that such deliverables are
                                         not delivered on or before November 11, 2016, the Company shall pay the Break-Up Fee
                                         to the Purchaser in immediately available funds on or before November 17, 2016.



 


		(k)	The
                                         Company (and as applicable, NACD) and the Purchaser shall comply with Section 2.5 herein.



 


		(l)	Within
                                         fifteen (15) days from the later to occur of (i) the First Closing and (ii) the date
                                         of delivery of First Closing documentation as described in Section 2.3(c) (for the avoidance
                                         of doubt, no later than November 11, 2016), the Company shall cause the pledge of the
                                         foreign Subsidiaries’ capital stock (as described in the Security Agreement) to
                                         be valid under any and all applicable U.S., foreign, and/or local laws, rules, and regulations.



 






    37


     

    

 


ARTICLE
V. 


MISCELLANEOUS



 


5.1
  Termination.  This Agreement may be terminated the Purchaser by written notice to the other parties, if the
First Closing has not been consummated on or before November 7, 2016; provided, however, that such termination will not affect
the right of any party to sue for any breach by any other party (or parties).


 


5.2
  Fees and Expenses.  The Company has agreed to reimburse the Purchaser’ legal counsel for its legal
fees as follows: (a) USD $10,000 at the First Closing; (b) USD $10,000 upon the closing of the second Tranche; (c) USD $10,000
upon the closing of the third Tranche; and (d) USD $10,000 upon the closing of the fourth Tranche. Notwithstanding the foregoing,
the Company acknowledges that it was obligated to pay the Purchaser a non-refundable legal retainer of $10,000 upon execution
of the term sheet containing the terms and conditions set forth in this Agreement. The Company shall deliver to the Purchaser,
prior to the First Closing, a completed and executed copy of the Closing Statement, attached hereto as Annex A. Except
as expressly set forth in the Transaction Documents to the contrary, each party shall pay the fees and expenses of its advisers,
counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to the negotiation, preparation,
execution, delivery and performance of this Agreement.


 


5.3
  Entire Agreement.  The Transaction Documents, together with the exhibits and schedules thereto, contain
the entire understanding of the parties with respect to the subject matter hereof and thereof and supersede all prior agreements
and understandings, oral or written, with respect to such matters, which the parties acknowledge have been merged into such documents,
exhibits and schedules.


 


5.4
  Notices.  Any and all notices or other communications or deliveries required or permitted to be provided
hereunder shall be in writing and shall be deemed given and effective on the earliest of: (i) the date of transmission, if such
notice or communication is delivered via facsimile at the facsimile number set forth on the signature pages attached hereto at
or prior to 12:00 p.m. (New York City time) on a Trading Day; (ii) the next Trading Day after the date of transmission, if such
notice or communication is delivered via facsimile at the facsimile number set forth on the signature pages attached hereto on
a day that is not a Trading Day or later than 12:00 p.m. (New York City time) on any Trading Day; (iii) the second (2nd)
Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service; or (iv) upon actual
receipt by the party to whom such notice is required to be given.  The address for such notices and communications shall
be as set forth on the signature pages attached hereto.


 


5.5
  Amendments; Waivers.  No provision of this Agreement may be waived, modified, supplemented or amended
except in a written instrument signed, in the case of an amendment, by the Company and the Purchaser, in the case of a waiver,
by the party against whom the enforcement of any such waived provision is sought.  No waiver of any default with respect
to any provision, condition or requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver
of any subsequent default or a waiver of any other provision, condition or requirement hereof, nor shall any delay or omission
of any party to exercise any right hereunder in any manner impair the exercise of any such right.


 


5.6
  Headings.  The headings herein are for convenience only, do not constitute a part of this Agreement and
shall not be deemed to limit or affect any of the provisions hereof.


 


5.7
  Successors and Assigns.  This Agreement shall be binding upon and inure to the benefit of the parties
and their successors and permitted assigns.  The Company may not assign this Agreement or any rights or obligations
hereunder without the prior written consent of the Purchaser (other than by merger).  The Purchaser may assign any or
all of its rights under this Agreement to any Person to whom the Purchaser assigns or transfers any Securities, provided that
such transferee agrees in writing to be bound, with respect to the transferred Securities, by the provisions of the Transaction
Documents that apply to the Purchaser as defined herein.


 






    38


     

    

 


5.8
  No Third-Party Beneficiaries.  This Agreement is intended for the benefit of the parties hereto and their
respective successors and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other
Person, except as otherwise set forth in Section 4.10.


 


5.9
  Governing Law.  All questions concerning the construction, validity, enforcement and interpretation of
the Transaction Documents shall be governed by and construed and enforced in accordance with the internal laws of the State of
New York, without regard to the principles of conflicts of law thereof.  Each party agrees that all legal proceedings
concerning the interpretations, enforcement and defense of the transactions contemplated by this Agreement and any other Transaction
Documents (whether brought against a party hereto or its respective affiliates, directors, officers, shareholders, partners, members,
employees or agents) shall be commenced exclusively in the state and federal courts sitting in the City of New York.  Each
party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York,
Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated
hereby or discussed herein (including with respect to the enforcement of any of the Transaction Documents), and hereby irrevocably
waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction
of any such court, that such suit, action or proceeding is improper or is an inconvenient venue for such proceeding.  Each
party hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding
by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at
the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient
service of process and notice thereof.  Nothing contained herein shall be deemed to limit in any way any right to serve
process in any other manner permitted by law.   If either party shall commence an action, suit or proceeding to
enforce any provisions of the Transaction Documents, then, in addition to the obligations of the Company under Section 4.10, the
prevailing party in such action, suit or proceeding shall be reimbursed by the other party for its reasonable attorneys’
fees and other costs and expenses incurred with the investigation, preparation and prosecution of such action or proceeding.


 


5.10
  Survival.  The representations and warranties contained herein shall survive the Closings and the delivery
of the Securities.


 


5.11
  Execution.  This Agreement may be executed in two or more counterparts, all of which when taken together
shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and
delivered to each other party, it being understood that the parties need not sign the same counterpart.  In the event
that any signature is delivered by facsimile transmission or by e-mail delivery of a “.pdf” format data file, such
signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with
the same force and effect as if such facsimile or “.pdf” signature page was an original thereof.


 






    39


     

    

 


5.12
  Severability. If any term, provision, covenant or restriction of this Agreement is held by a court of competent
jurisdiction to be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions
set forth herein shall remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties
hereto shall use their commercially reasonable efforts to find and employ an alternative means to achieve the same or substantially
the same result as that contemplated by such term, provision, covenant or restriction. It is hereby stipulated and declared to
be the intention of the parties that they would have executed the remaining terms, provisions, covenants and restrictions without
including any of such that may be hereafter declared invalid, illegal, void or unenforceable.


 


5.13
  Rescission and Withdrawal Right.  Notwithstanding anything to the contrary contained in (and without limiting
any similar provisions of) any of the other Transaction Documents, whenever the Purchaser exercises a right, election, demand
or option under a Transaction Document and the Company does not timely perform its related obligations within the periods therein
provided, then the Purchaser may rescind or withdraw, in its sole discretion from time to time upon written notice to the Company,
any relevant notice, demand or election in whole or in part without prejudice to its future actions and rights; provided, however,
that in the case of a rescission of a conversion of a Note, the applicable Purchaser shall be required to return any shares of
Common Stock subject to any such rescinded conversion notice concurrently with the return to the Purchaser of the aggregate exercise
price paid to the Company for such shares.


 


5.14
  Replacement of Securities.  If any certificate or instrument evidencing any Securities is mutilated, lost,
stolen or destroyed, the Company shall issue or cause to be issued in exchange and substitution for and upon cancellation thereof
(in the case of mutilation), or in lieu of and substitution therefor, a new certificate or instrument, but only upon receipt of
evidence reasonably satisfactory to the Company of such loss, theft or destruction.  The applicant for a new certificate
or instrument under such circumstances shall also pay any reasonable third-party costs (including customary indemnity) associated
with the issuance of such replacement Securities.


 


5.15
  Remedies.  In addition to being entitled to exercise all rights provided herein or granted by law, including
recovery of damages, the Purchaser and the Company will be entitled to specific performance under the Transaction Documents.  The
parties agree that monetary damages may not be adequate compensation for any loss incurred by reason of any breach of obligations
contained in the Transaction Documents and hereby agree to waive and not to assert in any action for specific performance of any
such obligation the defense that a remedy at law would be adequate.


 


5.16
  Payment Set Aside. To the extent that the Company makes a payment or payments to the Purchaser pursuant to any Transaction
Document or a Purchaser enforces or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement
or exercise or any part thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered
from, disgorged by or are required to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other
Person under any law (including, without limitation, any bankruptcy law, state or federal law, common law or equitable cause of
action), then to the extent of any such restoration the obligation or part thereof originally intended to be satisfied shall be
revived and continued in full force and effect as if such payment had not been made or such enforcement or setoff had not occurred.


 






    40


     

    

 


5.17
  Usury.  To the extent it may lawfully do so, the Company hereby agrees not to insist upon or plead or
in any manner whatsoever claim, and will resist any and all efforts to be compelled to take the benefit or advantage of, usury
laws wherever enacted, now or at any time hereafter in force, in connection with any claim, action or proceeding that may be brought
by the Purchaser in order to enforce any right or remedy under any Transaction Document.  Notwithstanding any provision
to the contrary contained in any Transaction Document, it is expressly agreed and provided that the total liability of the Company
under the Transaction Documents for payments in the nature of interest shall not exceed the maximum lawful rate authorized under
applicable law (the “Maximum Rate”), and, without limiting the foregoing, in no event shall any rate of interest or
default interest, or both of them, when aggregated with any other sums in the nature of interest that the Company may be obligated
to pay under the Transaction Documents exceed such Maximum Rate.  It is agreed that if the maximum contract rate of
interest allowed by law and applicable to the Transaction Documents is increased or decreased by statute or any official governmental
action subsequent to the date hereof, the new maximum contract rate of interest allowed by law will be the Maximum Rate applicable
to the Transaction Documents from the effective date thereof forward, unless such application is precluded by applicable law.  If
under any circumstances whatsoever, interest in excess of the Maximum Rate is paid by the Company to the Purchaser with respect
to indebtedness evidenced by the Transaction Documents, such excess shall be applied by the Purchaser to the unpaid principal
balance of any such indebtedness or be refunded to the Company, the manner of handling such excess to be at the Purchaser’s
election.


  


5.19
  Liquidated Damages.  The Company’s obligations to pay any partial liquidated damages or other amounts
owing under the Transaction Documents is a continuing obligation of the Company and shall not terminate until all unpaid partial
liquidated damages and other amounts have been paid notwithstanding the fact that the instrument or security pursuant to which
such partial liquidated damages or other amounts are due and payable shall have been canceled.


 


5.20Other
Fees. At the First Closing, the Company has agreed to reimburse the Purchaser $7,500 for expenses in connection with their
background checks of the principals of the Company.


 


5.21
  Saturdays, Sundays, Holidays, etc.  If the last or appointed day for the taking of any action or the expiration
of any right required or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised
on the next succeeding Business Day.


 


5.22
  Construction. The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity
to revise the Transaction Documents and, therefore, the normal rule of construction to the effect that any ambiguities are to
be resolved against the drafting party shall not be employed in the interpretation of the Transaction Documents or any amendments
thereto. In addition, each and every reference to share prices and shares of Common Stock in any Transaction Document shall be
subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations and other similar transactions
of the Common Stock that occur after the date of this Agreement. Additionally, the parties agree that any time it is reasonably
applicable for the word “Company” to be substituted or supplement with the word “NACD” in this Agreement,
such substitution or supplement shall be deemed made herein.


 


5.23
  WAIVER OF JURY TRIAL.  IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST
ANY OTHER PARTY, THE PARTIES EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY,
UNCONDITIONALLY, IRREVOCABLY AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY.


 


(Signature
Pages Follow) 


 




    41


     

    

 


IN
WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 


 





	NAC GLOBAL TECHNOLOGIES, INC.	 	Address for Notice:
	 	 	 	1800 West Loop South
	By:	/s/
    Antonio     Monesi	 	Suite 1115
	Name:	Antonio Monesi	 	Houston, Texas 77027
	Title:	President	 	 


 


	With a copy to (which shall not constitute
    notice):	 
	 	 
	Ellenoff Grossman & Schole LLP	 
	1345 Avenue of the Americas, Floor 11	 
	New York, NY 10105	 
	Attn:  Richard I. Anslow, Esq.	 
	Fax: (212) 370-7889	 


 





	NAC DRIVE SYSTEMS, INC.	 	Address for Notice:
	 	 	 	4720 Salisbury Road
	By:	/s/ Vincent Genovese	 	Jacksonville, FL 32256
	Name:	Vincent Genovese	 	
	Title:	Chief Executive Officer	 	


 


	With a copy to (which shall not constitute
    notice):	 
	 	 
	Ellenoff Grossman & Schole LLP	 
	1345 Avenue of the Americas, Floor 11	 
	New York, NY 10105	 
	Attn:  Richard I. Anslow, Esq.	 


 


[REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK 


SIGNATURE
PAGE FOR PURCHASER FOLLOWS] 


 






    42


     

    

 


[PURCHASER
SIGNATURE PAGES TO NAC GLOBAL TECHNOLOGIES, INC. SECURITIES PURCHASE AGREEMENT] 


 


IN
WITNESS WHEREOF, the undersigned has caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 


 


Name
of Purchaser:


 


Signature
of Authorized Signatory of Purchaser:  


 



Name
of Authorized Signatory: 


 


Title
of Authorized Signatory:  


 


Email
Address of Authorized


Signatory: ____________________________________


 


Facsimile
Number of Authorized


Signatory:
____________________________________


 


Address
for Notice to Purchaser: 


 


 


 


Address
for Delivery of Securities to Purchaser (if not same as address for notice): 


 


 


 


EIN
Number: _______________________ 


 


 


43